Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-let-7a-3p ABCA1 0.22 0.85543 0.03 0.97645 mirMAP; miRNATAP -0.39 0 NA
2 hsa-let-7a-3p ABCC9 0.22 0.85543 -0.59 0.22249 mirMAP -0.8 0 NA
3 hsa-let-7a-3p ABCD2 0.22 0.85543 0.42 0.49591 mirMAP -0.51 5.0E-5 NA
4 hsa-let-7a-3p ABI3BP 0.22 0.85543 0.35 0.57111 miRNATAP -0.62 2.0E-5 NA
5 hsa-let-7a-3p ACVR1 0.22 0.85543 -0.1 0.92895 MirTarget; miRNATAP -0.12 0.00024 NA
6 hsa-let-7a-3p ADAM23 0.22 0.85543 -0.22 0.68516 mirMAP -0.96 0 NA
7 hsa-let-7a-3p ADAMTS5 0.22 0.85543 -0.46 0.44877 mirMAP -0.36 0 NA
8 hsa-let-7a-3p ADAMTSL3 0.22 0.85543 -0.62 0.25659 MirTarget -1.14 0 NA
9 hsa-let-7a-3p ADCYAP1 0.22 0.85543 -0.9 0.19378 miRNATAP -1.12 0 NA
10 hsa-let-7a-3p ADD2 0.22 0.85543 -0.59 0.48027 mirMAP -0.74 0 NA
11 hsa-let-7a-3p AFF2 0.22 0.85543 -0.1 0.89663 mirMAP -0.35 0.012 NA
12 hsa-let-7a-3p AFF3 0.22 0.85543 0.07 0.87952 MirTarget -0.46 0.00048 NA
13 hsa-let-7a-3p AKAP12 0.22 0.85543 -0.67 0.54527 miRNATAP -0.88 0 NA
14 hsa-let-7a-3p ALDH1L2 0.22 0.85543 -0.66 0.34577 MirTarget -0.5 0 NA
15 hsa-let-7a-3p AMIGO2 0.22 0.85543 -0.84 0.41846 MirTarget; mirMAP -0.39 5.0E-5 NA
16 hsa-let-7a-3p AMOTL1 0.22 0.85543 -0.32 0.72722 mirMAP -0.64 0 NA
17 hsa-let-7a-3p ANKRD50 0.22 0.85543 0.17 0.87284 mirMAP -0.19 4.0E-5 NA
18 hsa-let-7a-3p ANO5 0.22 0.85543 -1.54 0.03199 mirMAP -0.59 0.00256 NA
19 hsa-let-7a-3p ANTXR1 0.22 0.85543 -0.41 0.78975 mirMAP; miRNATAP -0.79 0 NA
20 hsa-miR-106b-5p APC 0.3 0.86929 -0.2 0.85295 miRNAWalker2 validate; miRTarBase -0.22 0 23087084 miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells
21 hsa-miR-148a-3p APC 0.1 0.97698 -0.2 0.85295 miRNAWalker2 validate -0.12 0.00641 NA
22 hsa-miR-154-3p APC 0.17 0.5465 -0.2 0.85295 TargetScan -0.12 0.00356 NA
23 hsa-miR-192-5p APC 0.12 0.97293 -0.2 0.85295 miRNAWalker2 validate -0.11 0.00054 NA
24 hsa-miR-193a-3p APC 0.25 0.65436 -0.2 0.85295 miRanda -0.15 0.00011 NA
25 hsa-miR-27a-3p APC 0.12 0.9588 -0.2 0.85295 miRNAWalker2 validate; miRTarBase; miRNATAP -0.17 0.00984 22018270 Finally the APC gene was identified as the direct and functional target of miR-27
26 hsa-miR-335-3p APC 0.24 0.8845 -0.2 0.85295 mirMAP -0.21 0 NA
27 hsa-miR-374a-5p APC 0.34 0.76692 -0.2 0.85295 mirMAP -0.28 0 NA
28 hsa-miR-374b-5p APC 0.29 0.8357 -0.2 0.85295 mirMAP -0.2 0.00044 NA
29 hsa-miR-421 APC 0.18 0.7347 -0.2 0.85295 miRanda -0.15 0.0002 NA
30 hsa-miR-450b-5p APC 0.01 0.98315 -0.2 0.85295 miRNATAP -0.17 6.0E-5 NA
31 hsa-miR-501-3p APC 0.75 0.55276 -0.2 0.85295 TargetScan -0.12 0.00171 NA
32 hsa-miR-590-3p APC 0.28 0.59127 -0.2 0.85295 PITA; miRanda; mirMAP; miRNATAP -0.1 0.00339 NA
33 hsa-miR-199a-5p APC2 -0.16 0.9358 0.38 0.36375 mirMAP -0.25 0.01352 NA
34 hsa-miR-20a-3p APC2 -0.46 0.57674 0.38 0.36375 mirMAP -0.17 0.00956 NA
35 hsa-miR-221-5p APC2 -0.08 0.8976 0.38 0.36375 mirMAP -0.15 0.02524 NA
36 hsa-miR-452-3p APC2 0.17 0.79901 0.38 0.36375 mirMAP -0.17 0.00953 NA
37 hsa-miR-500a-3p APC2 0.63 0.73258 0.38 0.36375 mirMAP -0.23 0.01164 NA
38 hsa-let-7a-3p AQP9 0.22 0.85543 0.03 0.96356 MirTarget -0.89 0 NA
39 hsa-let-7a-3p ARHGAP20 0.22 0.85543 -0.29 0.53474 MirTarget; miRNATAP -0.61 0 NA
40 hsa-let-7a-3p ARHGAP28 0.22 0.85543 0.02 0.95412 mirMAP -0.39 0.00025 NA
41 hsa-let-7a-3p ARHGAP29 0.22 0.85543 -0.16 0.86195 mirMAP -0.27 0.00025 NA
42 hsa-let-7a-3p ARL10 0.22 0.85543 -0.21 0.63068 mirMAP -0.55 0 NA
43 hsa-let-7a-3p ARSB 0.22 0.85543 0.25 0.77683 mirMAP -0.17 0.00258 NA
44 hsa-let-7a-3p ASAH1 0.22 0.85543 0.39 0.80879 MirTarget -0.14 0.00225 NA
45 hsa-let-7a-3p ASAP1 0.22 0.85543 -0.41 0.73426 mirMAP -0.19 0.0006 NA
46 hsa-let-7a-3p ASXL2 0.22 0.85543 0.15 0.89512 mirMAP; miRNATAP -0.18 0.00081 NA
47 hsa-let-7a-3p ATE1 0.22 0.85543 0.27 0.75611 mirMAP -0.13 0.00265 NA
48 hsa-let-7a-3p ATF2 0.22 0.85543 0.2 0.8347 MirTarget; mirMAP; miRNATAP -0.15 4.0E-5 NA
49 hsa-let-7a-3p ATP6AP2 0.22 0.85543 0.06 0.96911 mirMAP -0.13 0.00027 NA
50 hsa-let-7a-3p ATRN 0.22 0.85543 0.42 0.74342 miRNATAP -0.26 8.0E-5 NA
51 hsa-let-7a-3p ATRX 0.22 0.85543 0.04 0.97477 MirTarget; miRNATAP -0.13 0.00051 NA
52 hsa-miR-34c-5p AXIN2 0.02 0.95279 -0.16 0.92249 miRanda -0.24 0.02386 NA
53 hsa-miR-582-5p AXIN2 0.4 0.58123 -0.16 0.92249 miRNATAP -0.54 0 NA
54 hsa-let-7a-3p B3GALNT1 0.22 0.85543 -0.71 0.20409 mirMAP -0.37 0.00031 NA
55 hsa-let-7a-3p BAG4 0.22 0.85543 0.39 0.56669 mirMAP -0.2 0.00021 NA
56 hsa-let-7a-3p BASP1 0.22 0.85543 -0.42 0.63739 miRNATAP -0.46 0 NA
57 hsa-let-7a-3p BCL6 0.22 0.85543 -0.02 0.97914 miRNATAP -0.17 0.00802 NA
58 hsa-let-7a-3p BDNF 0.22 0.85543 -0.5 0.16933 MirTarget; miRNATAP -0.24 0.00935 NA
59 hsa-let-7a-3p BEND4 0.22 0.85543 -0.29 0.75243 mirMAP -0.41 0.00473 NA
60 hsa-let-7a-3p BEND6 0.22 0.85543 -0.45 0.38458 mirMAP -0.77 0 NA
61 hsa-let-7a-3p BICD2 0.22 0.85543 0.01 0.99011 mirMAP -0.1 0.00472 NA
62 hsa-let-7a-3p BMP2K 0.22 0.85543 0.17 0.84483 mirMAP -0.17 6.0E-5 NA
63 hsa-let-7a-3p BMP3 0.22 0.85543 -1.04 0.20452 MirTarget; mirMAP -0.82 0.00029 NA
64 hsa-let-7a-3p BMPR1B 0.22 0.85543 -0.03 0.96601 miRNATAP -0.61 0.00028 NA
65 hsa-let-7a-3p BMPR2 0.22 0.85543 -0.18 0.9 MirTarget; miRNATAP -0.18 0.00013 NA
66 hsa-let-7a-3p BNC2 0.22 0.85543 -0.3 0.61151 mirMAP -0.77 0 NA
67 hsa-let-7a-3p BST1 0.22 0.85543 -0.48 0.33816 MirTarget -0.38 0.00024 NA
68 hsa-let-7a-3p BTC 0.22 0.85543 -0 0.99638 mirMAP -0.2 0.00283 NA
69 hsa-let-7a-3p BVES 0.22 0.85543 -0.39 0.30397 mirMAP -0.64 0 NA
70 hsa-let-7a-3p CACNA1C 0.22 0.85543 -0.62 0.47829 MirTarget -0.23 0.03112 NA
71 hsa-let-7a-3p CACNA2D1 0.22 0.85543 -0.21 0.75224 mirMAP -1.24 0 NA
72 hsa-let-7a-3p CACNG4 0.22 0.85543 -1.67 0.05751 MirTarget -0.55 0.03405 NA
73 hsa-miR-195-3p CACYBP -0.12 0.69192 -0.04 0.97693 mirMAP -0.15 0 NA
74 hsa-miR-30a-3p CACYBP -0.25 0.91709 -0.04 0.97693 MirTarget -0.23 0 NA
75 hsa-miR-182-5p CAMK2B 0.1 0.97338 -2.17 0.00982 mirMAP -0.23 0.04992 NA
76 hsa-miR-186-5p CAMK2B 0.32 0.85413 -2.17 0.00982 miRNAWalker2 validate; miRNATAP -0.92 0 NA
77 hsa-miR-18a-5p CAMK2B 0.5 0.61264 -2.17 0.00982 mirMAP -0.33 0.00078 NA
78 hsa-miR-18b-5p CAMK2B 0.05 0.89998 -2.17 0.00982 mirMAP -0.21 0.03116 NA
79 hsa-miR-335-5p CAMK2B 0.03 0.97338 -2.17 0.00982 mirMAP -0.3 0.01498 NA
80 hsa-miR-34a-5p CAMK2B 0.5 0.74203 -2.17 0.00982 mirMAP -0.28 0.04878 NA
81 hsa-miR-362-3p CAMK2B 0.72 0.03459 -2.17 0.00982 miRanda -0.39 0.00026 NA
82 hsa-miR-362-5p CAMK2B 0.27 0.75202 -2.17 0.00982 miRNATAP -0.43 3.0E-5 NA
83 hsa-miR-377-3p CAMK2B 0.04 0.89351 -2.17 0.00982 mirMAP -0.3 0.01013 NA
84 hsa-miR-491-5p CAMK2B 0.59 0.04526 -2.17 0.00982 miRanda -0.24 0.04944 NA
85 hsa-miR-577 CAMK2B 1.06 0.32606 -2.17 0.00982 miRNATAP -0.33 0 NA
86 hsa-miR-589-3p CAMK2B 0.84 0.0112 -2.17 0.00982 MirTarget -0.47 0 NA
87 hsa-miR-590-3p CAMK2B 0.28 0.59127 -2.17 0.00982 miRanda -0.42 0.00016 NA
88 hsa-miR-625-5p CAMK2B 0.69 0.21031 -2.17 0.00982 mirMAP -0.4 3.0E-5 NA
89 hsa-miR-628-5p CAMK2B 0.51 0.35193 -2.17 0.00982 miRNATAP -0.53 0.00189 NA
90 hsa-miR-940 CAMK2B 0.23 0.68006 -2.17 0.00982 PITA; miRNATAP -0.25 0.0094 NA
91 hsa-miR-96-5p CAMK2B -0.09 0.92309 -2.17 0.00982 mirMAP -0.29 0.01248 NA
92 hsa-miR-361-5p CAMK2D 0.14 0.9415 0.33 0.80466 PITA; miRanda; miRNATAP -0.15 0.03044 NA
93 hsa-miR-542-3p CAMK2D -0.19 0.90925 0.33 0.80466 miRanda -0.11 0.03439 NA
94 hsa-miR-708-3p CAMK2D -0.14 0.89698 0.33 0.80466 mirMAP -0.14 0.00023 NA
95 hsa-miR-181a-5p CAMK2G -0.03 0.98933 -0.21 0.86839 miRNATAP -0.1 0.00195 NA
96 hsa-miR-181b-5p CAMK2G -0.16 0.93018 -0.21 0.86839 miRNATAP -0.1 0.00173 NA
97 hsa-miR-30e-3p CAMK2G 0.22 0.93866 -0.21 0.86839 MirTarget -0.1 0.04583 NA
98 hsa-miR-628-5p CAMK2G 0.51 0.35193 -0.21 0.86839 MirTarget; PITA; miRNATAP -0.17 0 NA
99 hsa-let-7a-3p CCDC102B 0.22 0.85543 -0.45 0.1566 MirTarget -0.29 0.00016 NA
100 hsa-let-7a-3p CCDC50 0.22 0.85543 -0.18 0.8903 miRNATAP -0.14 0 NA
101 hsa-miR-15a-5p CCND1 0.07 0.96484 0.25 0.89067 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.13 0.01564 22922827 CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR
102 hsa-miR-15b-5p CCND1 0.27 0.87097 0.25 0.89067 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.1 0.03897 NA
103 hsa-miR-16-5p CCND1 -0.01 0.99448 0.25 0.89067 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.13 0.00823 23991964; 22922827; 18483394 At the molecular level our results further revealed that cyclin D1 expression was negatively regulated by miR-16;CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL
104 hsa-miR-195-5p CCND1 -0.34 0.74962 0.25 0.89067 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.14 0.00272 21350001; 26631043; 25823925 Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer;MiR 195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1; The present study was to evaluate the level of miR-195 and cyclin D1 in CC tissues and cells; We further investigated the molecular mechanisms of miR-195 and cyclin D1 in CC cell lines HeLa and SiHa; Furthermore the expression of miR-195 was inversely proportional to that of cyclin D1 mRNA or protein pā€‰=ā€‰0.013 pā€‰=ā€‰0.015 respectively; However the inhibitor of miR-195 promoted the expression of cyclin D1 and cell proliferation; In conclusion our data suggest that miR-195 may have the potential role in treatment of CC patients as well as miR-195 is a novel regulator of invasiveness and tumorigenicity in CC cells by targeting cyclin D1;MicroRNA profiling identifies MiR 195 suppresses osteosarcoma cell metastasis by targeting CCND1; Meanwhile CCND1 was identified as the target gene of miR-195 and further studied; More importantly using real-time PCR we evaluated the expression of miR-195 and CCND1 in osteosarcoma samples from 107 frozen biopsy tissues and 99 formalin- or paraformalin-fixed paraffin-embedded FFPE tissues; Results indicated lowly expressed miR-195 or highly CCND1 correlated with positive overall survival and their expression inversely related to each other; In summary our study suggests miR-195 functions as a tumor metastasis suppressor gene by down-regulating CCND1 and can be used as a potential target in the treatment of osteosarcoma
105 hsa-miR-26b-5p CCND1 0.02 0.99038 0.25 0.89067 miRNAWalker2 validate -0.13 0.03302 NA
106 hsa-miR-29c-3p CCND1 -0.16 0.94272 0.25 0.89067 mirMAP -0.14 0.00181 NA
107 hsa-miR-301a-3p CCND2 0.11 0.83169 0.17 0.92031 miRNAWalker2 validate -0.18 0.02477 NA
108 hsa-let-7a-3p CCPG1 0.22 0.85543 -0.16 0.90622 mirMAP -0.18 0.00016 NA
109 hsa-let-7a-3p CD109 0.22 0.85543 -0.24 0.78871 mirMAP -0.58 7.0E-5 NA
110 hsa-let-7a-3p CD302 0.22 0.85543 -0.05 0.96052 mirMAP -0.17 0.00116 NA
111 hsa-let-7a-3p CD38 0.22 0.85543 0.28 0.61945 MirTarget -0.66 4.0E-5 NA
112 hsa-let-7a-3p CDC14A 0.22 0.85543 -0.02 0.9701 mirMAP -0.15 0.00458 NA
113 hsa-let-7a-3p CDC42EP3 0.22 0.85543 -0.16 0.87255 MirTarget; mirMAP -0.25 3.0E-5 NA
114 hsa-let-7a-3p CDK17 0.22 0.85543 0.13 0.89542 MirTarget; miRNATAP -0.12 0.00022 NA
115 hsa-let-7a-3p CDS2 0.22 0.85543 0.14 0.90229 mirMAP -0.12 0.00961 NA
116 hsa-let-7a-3p CFL2 0.22 0.85543 -0.17 0.83413 mirMAP -0.42 0 NA
117 hsa-miR-24-3p CHD8 0.05 0.98527 0.23 0.87207 miRNAWalker2 validate -0.17 0.00183 NA
118 hsa-let-7a-3p CHL1 0.22 0.85543 -0.1 0.86218 MirTarget; miRNATAP -0.94 0 NA
119 hsa-let-7a-3p CHM 0.22 0.85543 0.03 0.97474 MirTarget -0.13 0.00246 NA
120 hsa-miR-1254 CHP2 0.49 0.19552 -1.47 0.1548 miRNATAP -0.41 0.02445 NA
121 hsa-let-7a-3p CHST2 0.22 0.85543 0.01 0.98837 MirTarget -0.3 0.0002 NA
122 hsa-let-7a-3p CLIC4 0.22 0.85543 -0.32 0.83486 MirTarget -0.38 0 NA
123 hsa-let-7a-3p CLIP1 0.22 0.85543 0.01 0.99459 miRNATAP -0.13 3.0E-5 NA
124 hsa-let-7a-3p CLOCK 0.22 0.85543 0.11 0.90421 MirTarget -0.12 0.02498 NA
125 hsa-let-7a-3p CNR1 0.22 0.85543 -0.41 0.59275 mirMAP -0.91 0 NA
126 hsa-let-7a-3p CNTN1 0.22 0.85543 -0.7 0.42296 MirTarget; miRNATAP -1.19 0 NA
127 hsa-let-7a-3p COL11A1 0.22 0.85543 -0.44 0.71516 MirTarget; miRNATAP -0.97 0 NA
128 hsa-let-7a-3p COL12A1 0.22 0.85543 -0.32 0.85805 miRNATAP -0.53 0 NA
129 hsa-let-7a-3p COL15A1 0.22 0.85543 -0.29 0.84045 MirTarget -0.44 0 NA
130 hsa-let-7a-3p COL1A2 0.22 0.85543 -0.45 0.85135 MirTarget -0.58 0 NA
131 hsa-let-7a-3p COL4A1 0.22 0.85543 -0.39 0.84353 miRNATAP -0.37 0 NA
132 hsa-let-7a-3p COL9A1 0.22 0.85543 -1.12 0.11959 mirMAP -0.49 0.0225 NA
133 hsa-let-7a-3p CORO1C 0.22 0.85543 0.11 0.94638 MirTarget; miRNATAP -0.12 0.00019 NA
134 hsa-let-7a-3p CPEB4 0.22 0.85543 -0.27 0.79855 mirMAP; miRNATAP -0.2 5.0E-5 NA
135 hsa-miR-493-5p CREBBP -0.23 0.73198 0.07 0.96314 miRNATAP -0.13 0.00036 NA
136 hsa-let-7a-3p CRISPLD1 0.22 0.85543 -0.38 0.4497 MirTarget; miRNATAP -0.82 0 NA
137 hsa-miR-21-5p CSNK1A1 0.15 0.97024 -0.04 0.98107 miRNAWalker2 validate -0.1 0.01247 NA
138 hsa-miR-30e-5p CSNK1A1 0.07 0.97968 -0.04 0.98107 MirTarget -0.11 0.00277 NA
139 hsa-miR-330-3p CSNK1A1L -0 0.9945 0.09 0.90544 PITA -0.16 0.04934 NA
140 hsa-miR-26a-5p CSNK2A1 -0.01 0.99772 0.07 0.95967 mirMAP -0.15 0.03995 NA
141 hsa-miR-146b-5p CSNK2A2 0.4 0.83751 -0.05 0.96212 miRanda -0.17 0 NA
142 hsa-miR-212-3p CSNK2A2 0.02 0.97323 -0.05 0.96212 mirMAP -0.12 0.00416 NA
143 hsa-miR-92b-3p CSNK2A2 0.57 0.68932 -0.05 0.96212 mirMAP -0.11 0.00058 NA
144 hsa-miR-140-5p CTNNB1 0.23 0.84733 0.27 0.89738 miRanda -0.14 0.00185 NA
145 hsa-let-7a-3p CTSC 0.22 0.85543 -0.01 0.99667 mirMAP -0.13 0.00792 NA
146 hsa-let-7a-3p CUL4B 0.22 0.85543 -0.02 0.98956 mirMAP -0.1 0.00249 NA
147 hsa-let-7a-3p CX3CR1 0.22 0.85543 0.43 0.29379 MirTarget -0.65 0 NA
148 hsa-let-7a-3p CXXC4 0.22 0.85543 -0.79 0.21218 mirMAP -0.32 0.01577 NA
149 hsa-let-7f-1-3p CXXC4 0.31 0.69341 -0.79 0.21218 mirMAP -0.52 0.00404 NA
150 hsa-miR-126-5p CXXC4 -0.08 0.95664 -0.79 0.21218 MirTarget; mirMAP -0.43 0.00513 NA
NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALING PATHWAY 78 351 5.661e-51 2.634e-47
2 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 140 1672 1.801e-38 4.19e-35
3 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 103 1021 1.675e-34 2.599e-31
4 NEUROGENESIS 120 1402 1.86e-33 2.164e-30
5 CANONICAL WNT SIGNALING PATHWAY 36 95 5.13e-33 4.774e-30
6 REGULATION OF CELL DIFFERENTIATION 123 1492 9.363e-33 7.261e-30
7 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 103 1142 2.329e-30 1.548e-27
8 CARDIOVASCULAR SYSTEM DEVELOPMENT 83 788 5.883e-29 3.041e-26
9 CIRCULATORY SYSTEM DEVELOPMENT 83 788 5.883e-29 3.041e-26
10 REGULATION OF WNT SIGNALING PATHWAY 51 310 8.19e-27 3.464e-24
11 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 109 1395 7.707e-27 3.464e-24
12 CELL DEVELOPMENT 110 1426 1.255e-26 4.864e-24
13 NEURON DIFFERENTIATION 84 874 1.608e-26 5.756e-24
14 REGULATION OF CELL DEVELOPMENT 81 836 8.449e-26 2.808e-23
15 POSITIVE REGULATION OF CELL DIFFERENTIATION 80 823 1.425e-25 4.42e-23
16 TISSUE DEVELOPMENT 112 1518 1.69e-25 4.915e-23
17 TUBE DEVELOPMENT 65 552 2.121e-25 5.806e-23
18 REGULATION OF ORGAN MORPHOGENESIS 44 242 4.307e-25 1.113e-22
19 POSITIVE REGULATION OF CELL COMMUNICATION 110 1532 4.704e-24 1.152e-21
20 NON CANONICAL WNT SIGNALING PATHWAY 34 140 6.056e-24 1.409e-21
21 POSITIVE REGULATION OF RESPONSE TO STIMULUS 125 1929 1.683e-23 3.729e-21
22 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 83 957 3.223e-23 6.817e-21
23 ORGAN MORPHOGENESIS 77 841 5.518e-23 1.116e-20
24 TISSUE MORPHOGENESIS 59 533 9.716e-22 1.884e-19
25 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 73 801 1.105e-21 2.057e-19
26 HEART DEVELOPMENT 55 466 1.244e-21 2.226e-19
27 REGULATION OF CELL DEATH 102 1472 4.328e-21 7.458e-19
28 NEGATIVE REGULATION OF CELL COMMUNICATION 90 1192 5.042e-21 8.379e-19
29 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 36 197 8.433e-21 1.353e-18
30 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 69 750 9.677e-21 1.501e-18
31 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 56 513 2.215e-20 3.325e-18
32 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 108 1656 2.385e-20 3.468e-18
33 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 101 1492 3.829e-20 5.399e-18
34 MORPHOGENESIS OF AN EPITHELIUM 49 400 4.697e-20 6.428e-18
35 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 45 337 5.433e-20 7.222e-18
36 CELLULAR COMPONENT MORPHOGENESIS 75 900 5.675e-20 7.335e-18
37 TUBE MORPHOGENESIS 44 323 6.507e-20 8.184e-18
38 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 95 1360 7.523e-20 9.212e-18
39 POSITIVE REGULATION OF GENE EXPRESSION 109 1733 2.361e-19 2.817e-17
40 EPITHELIUM DEVELOPMENT 76 945 2.471e-19 2.874e-17
41 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 37 236 5.386e-19 6.113e-17
42 VASCULATURE DEVELOPMENT 51 469 1.456e-18 1.614e-16
43 EMBRYO DEVELOPMENT 72 894 2.282e-18 2.469e-16
44 POSITIVE REGULATION OF MOLECULAR FUNCTION 109 1791 2.715e-18 2.871e-16
45 NEGATIVE REGULATION OF CELL DIFFERENTIATION 58 609 3.118e-18 3.224e-16
46 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 111 1848 3.245e-18 3.282e-16
47 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 78 1036 3.726e-18 3.612e-16
48 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 78 1036 3.726e-18 3.612e-16
49 EMBRYONIC MORPHOGENESIS 54 539 5.326e-18 5.057e-16
50 REGULATION OF STEM CELL DIFFERENTIATION 26 113 5.746e-18 5.347e-16
51 REGULATION OF CELLULAR COMPONENT MOVEMENT 65 771 1.265e-17 1.154e-15
52 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 82 1152 1.301e-17 1.164e-15
53 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 108 1805 1.385e-17 1.216e-15
54 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 87 1275 1.551e-17 1.337e-15
55 LOCOMOTION 80 1114 2.07e-17 1.751e-15
56 CENTRAL NERVOUS SYSTEM DEVELOPMENT 69 872 3.195e-17 2.654e-15
57 INTRACELLULAR SIGNAL TRANSDUCTION 98 1572 4.276e-17 3.49e-15
58 POSITIVE REGULATION OF CELL DEVELOPMENT 49 472 4.815e-17 3.862e-15
59 SENSORY ORGAN DEVELOPMENT 50 493 5.943e-17 4.687e-15
60 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 80 1135 6.081e-17 4.716e-15
61 CELL FATE COMMITMENT 34 227 6.361e-17 4.852e-15
62 REGULATION OF CELL MORPHOGENESIS 53 552 6.967e-17 5.229e-15
63 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 29 162 9.697e-17 7.162e-15
64 MESENCHYME DEVELOPMENT 31 190 1.294e-16 9.411e-15
65 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 105 1784 1.38e-16 9.877e-15
66 RESPONSE TO ENDOGENOUS STIMULUS 92 1450 1.607e-16 1.133e-14
67 REGULATION OF PROTEIN MODIFICATION PROCESS 102 1710 1.708e-16 1.186e-14
68 HEAD DEVELOPMENT 60 709 2.129e-16 1.457e-14
69 BLOOD VESSEL MORPHOGENESIS 42 364 2.186e-16 1.474e-14
70 REGULATION OF PHOSPHORUS METABOLIC PROCESS 98 1618 2.857e-16 1.899e-14
71 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 52 554 3.609e-16 2.365e-14
72 NEGATIVE REGULATION OF CELL DEATH 67 872 4.244e-16 2.743e-14
73 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 16 39 5.073e-16 3.234e-14
74 REGULATION OF TRANSPORT 104 1804 8.156e-16 5.128e-14
75 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 72 1004 1.118e-15 6.86e-14
76 REGULATION OF CELL PROLIFERATION 92 1496 1.12e-15 6.86e-14
77 RESPONSE TO GROWTH FACTOR 47 475 1.399e-15 8.453e-14
78 HEART MORPHOGENESIS 31 212 3.062e-15 1.827e-13
79 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 70 983 4.19e-15 2.468e-13
80 RESPONSE TO OXYGEN CONTAINING COMPOUND 86 1381 5.599e-15 3.256e-13
81 SKELETAL SYSTEM DEVELOPMENT 45 455 5.913e-15 3.397e-13
82 CELL PROJECTION ORGANIZATION 66 902 7.711e-15 4.376e-13
83 REGULATION OF EPITHELIAL CELL PROLIFERATION 35 285 1.139e-14 6.385e-13
84 NEURON PROJECTION DEVELOPMENT 49 545 1.458e-14 8.075e-13
85 PROTEIN PHOSPHORYLATION 67 944 2.048e-14 1.121e-12
86 REGULATION OF NEURON DIFFERENTIATION 49 554 2.74e-14 1.483e-12
87 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 22 110 4.739e-14 2.478e-12
88 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 60 799 4.721e-14 2.478e-12
89 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 69 1008 4.667e-14 2.478e-12
90 REGULATION OF BINDING 34 283 5.287e-14 2.733e-12
91 STEM CELL DIFFERENTIATION 28 190 5.637e-14 2.882e-12
92 NEGATIVE REGULATION OF GENE EXPRESSION 88 1493 6.218e-14 3.145e-12
93 MUSCLE STRUCTURE DEVELOPMENT 42 432 8.907e-14 4.457e-12
94 REGULATION OF EMBRYONIC DEVELOPMENT 22 114 1.03e-13 5.1e-12
95 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 88 1517 1.539e-13 7.537e-12
96 POSITIVE REGULATION OF CATALYTIC ACTIVITY 88 1518 1.597e-13 7.741e-12
97 EMBRYONIC ORGAN DEVELOPMENT 40 406 2.311e-13 1.109e-11
98 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 56 740 2.599e-13 1.234e-11
99 GROWTH 40 410 3.179e-13 1.494e-11
100 REGULATION OF CELLULAR COMPONENT BIOGENESIS 57 767 3.323e-13 1.546e-11
101 OUTFLOW TRACT MORPHOGENESIS 16 56 3.766e-13 1.735e-11
102 MESENCHYMAL CELL DIFFERENTIATION 23 134 3.846e-13 1.755e-11
103 RESPONSE TO LIPID 62 888 4.41e-13 1.992e-11
104 REGULATION OF DEVELOPMENTAL GROWTH 33 289 5.324e-13 2.382e-11
105 NEURON DEVELOPMENT 53 687 5.63e-13 2.495e-11
106 CELLULAR RESPONSE TO LIPID 42 457 5.931e-13 2.583e-11
107 PATTERN SPECIFICATION PROCESS 40 418 5.939e-13 2.583e-11
108 REGIONALIZATION 34 311 8.225e-13 3.544e-11
109 REGULATION OF HYDROLASE ACTIVITY 79 1327 9.028e-13 3.819e-11
110 MORPHOGENESIS OF A BRANCHING STRUCTURE 25 167 8.951e-13 3.819e-11
111 REGULATION OF MAPK CASCADE 51 660 1.499e-12 6.285e-11
112 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 40 437 2.458e-12 1.012e-10
113 REGULATION OF CELLULAR RESPONSE TO STRESS 52 691 2.45e-12 1.012e-10
114 POSITIVE REGULATION OF CELL DEATH 48 605 2.778e-12 1.134e-10
115 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 24 162 3.238e-12 1.31e-10
116 REGULATION OF OSSIFICATION 25 178 3.851e-12 1.545e-10
117 DEVELOPMENTAL GROWTH 34 333 5.702e-12 2.267e-10
118 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 16 67 7.859e-12 3.099e-10
119 REGULATION OF CELL PROJECTION ORGANIZATION 45 558 8.012e-12 3.133e-10
120 PHOSPHORYLATION 73 1228 8.116e-12 3.147e-10
121 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 28 232 8.369e-12 3.218e-10
122 POSITIVE REGULATION OF CELL PROLIFERATION 56 814 1.191e-11 4.542e-10
123 REGULATION OF GROWTH 48 633 1.385e-11 5.241e-10
124 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 20 117 1.443e-11 5.416e-10
125 EYE DEVELOPMENT 33 326 1.488e-11 5.541e-10
126 ANGIOGENESIS 31 293 2.015e-11 7.439e-10
127 REGULATION OF NEURON PROJECTION DEVELOPMENT 37 408 2.209e-11 8.094e-10
128 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 58 876 2.299e-11 8.356e-10
129 DIGESTIVE SYSTEM DEVELOPMENT 22 148 2.443e-11 8.812e-10
130 NEURAL TUBE DEVELOPMENT 22 149 2.8e-11 1.002e-09
131 POSITIVE REGULATION OF OSSIFICATION 17 84 3.013e-11 1.07e-09
132 CELL MOTILITY 56 835 3.204e-11 1.121e-09
133 LOCALIZATION OF CELL 56 835 3.204e-11 1.121e-09
134 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 10 22 4.938e-11 1.715e-09
135 POSITIVE REGULATION OF LOCOMOTION 37 420 5.122e-11 1.765e-09
136 POSITIVE REGULATION OF KINASE ACTIVITY 40 482 5.163e-11 1.766e-09
137 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 22 154 5.441e-11 1.848e-09
138 CELLULAR RESPONSE TO RETINOIC ACID 15 65 6.046e-11 2.039e-09
139 SINGLE ORGANISM BEHAVIOR 35 384 6.799e-11 2.276e-09
140 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 26 220 7.547e-11 2.508e-09
141 CELL PROLIFERATION 48 672 1.098e-10 3.623e-09
142 BEHAVIOR 41 516 1.123e-10 3.68e-09
143 REGULATION OF RESPONSE TO STRESS 79 1468 1.337e-10 4.351e-09
144 EMBRYONIC ORGAN MORPHOGENESIS 29 279 1.392e-10 4.498e-09
145 RHYTHMIC PROCESS 30 298 1.466e-10 4.705e-09
146 UROGENITAL SYSTEM DEVELOPMENT 30 299 1.592e-10 5.074e-09
147 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 20 134 1.839e-10 5.821e-09
148 RESPONSE TO RETINOIC ACID 18 107 2.001e-10 6.251e-09
149 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 48 684 2.002e-10 6.251e-09
150 RESPIRATORY SYSTEM DEVELOPMENT 24 197 2.169e-10 6.727e-09
151 NEGATIVE REGULATION OF CELL DEVELOPMENT 30 303 2.204e-10 6.791e-09
152 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 13 50 2.31e-10 7.07e-09
153 TAXIS 38 464 2.339e-10 7.114e-09
154 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 35 404 2.728e-10 8.241e-09
155 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 96 1977 2.814e-10 8.448e-09
156 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 10 26 3.703e-10 1.104e-08
157 RESPONSE TO ORGANIC CYCLIC COMPOUND 57 917 3.894e-10 1.154e-08
158 MUSCLE CELL DIFFERENTIATION 26 237 3.93e-10 1.157e-08
159 REGULATION OF OSTEOBLAST DIFFERENTIATION 18 112 4.35e-10 1.273e-08
160 REGULATION OF MUSCLE ADAPTATION 14 63 4.538e-10 1.32e-08
161 SENSORY ORGAN MORPHOGENESIS 26 239 4.724e-10 1.365e-08
162 NEURON PROJECTION GUIDANCE 24 205 4.957e-10 1.424e-08
163 REGULATION OF SYNAPSE ORGANIZATION 18 113 5.055e-10 1.443e-08
164 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 13 53 5.109e-10 1.449e-08
165 BIOLOGICAL ADHESION 61 1032 6.487e-10 1.829e-08
166 TUBE FORMATION 19 129 6.627e-10 1.858e-08
167 CELLULAR RESPONSE TO ACID CHEMICAL 22 175 6.74e-10 1.878e-08
168 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 20 144 6.842e-10 1.895e-08
169 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 19 131 8.663e-10 2.385e-08
170 SOMITE DEVELOPMENT 15 78 9.409e-10 2.575e-08
171 EPITHELIAL TO MESENCHYMAL TRANSITION 13 56 1.071e-09 2.913e-08
172 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 34 406 1.199e-09 3.244e-08
173 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 23 197 1.206e-09 3.244e-08
174 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 37 470 1.217e-09 3.253e-08
175 REGULATION OF CELL ADHESION 44 629 1.313e-09 3.492e-08
176 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 28 289 1.454e-09 3.845e-08
177 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 32 368 1.478e-09 3.885e-08
178 REGULATION OF KINASE ACTIVITY 50 776 1.54e-09 4.026e-08
179 REGULATION OF PROTEIN IMPORT 22 183 1.59e-09 4.134e-08
180 NEURAL TUBE FORMATION 16 94 1.709e-09 4.419e-08
181 DIGESTIVE TRACT MORPHOGENESIS 12 48 1.881e-09 4.835e-08
182 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 43 616 2.176e-09 5.563e-08
183 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 46 689 2.398e-09 6.097e-08
184 NEGATIVE REGULATION OF CELL PROLIFERATION 44 643 2.58e-09 6.525e-08
185 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 13 60 2.668e-09 6.711e-08
186 KIDNEY EPITHELIUM DEVELOPMENT 18 125 2.713e-09 6.787e-08
187 REGULATION OF SYSTEM PROCESS 38 507 2.835e-09 7.055e-08
188 CELL CELL SIGNALING 49 767 3.004e-09 7.435e-08
189 REGULATION OF CELL SUBSTRATE ADHESION 21 173 3.14e-09 7.731e-08
190 RESPONSE TO ACID CHEMICAL 29 319 3.217e-09 7.877e-08
191 PALATE DEVELOPMENT 15 85 3.292e-09 8.02e-08
192 NEURON PROJECTION MORPHOGENESIS 33 402 3.487e-09 8.451e-08
193 NEGATIVE REGULATION OF MOLECULAR FUNCTION 61 1079 3.578e-09 8.627e-08
194 REGULATION OF PROTEIN LOCALIZATION 56 950 3.848e-09 9.23e-08
195 REGULATION OF NEURON APOPTOTIC PROCESS 22 192 3.947e-09 9.418e-08
196 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 28 303 4.198e-09 9.965e-08
197 POSITIVE REGULATION OF MAPK CASCADE 36 470 4.247e-09 1.003e-07
198 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 24 229 4.682e-09 1.1e-07
199 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 31 365 4.707e-09 1.101e-07
200 SYNAPSE ORGANIZATION 19 145 4.935e-09 1.142e-07
201 POSITIVE REGULATION OF HYDROLASE ACTIVITY 54 905 4.924e-09 1.142e-07
202 REPRODUCTIVE SYSTEM DEVELOPMENT 33 408 5.04e-09 1.161e-07
203 NEURAL CREST CELL DIFFERENTIATION 14 75 5.151e-09 1.181e-07
204 POSITIVE REGULATION OF NEURON DIFFERENTIATION 28 306 5.222e-09 1.191e-07
205 CARTILAGE DEVELOPMENT 19 147 6.218e-09 1.411e-07
206 SEGMENTATION 15 89 6.365e-09 1.438e-07
207 REGULATION OF CYTOSKELETON ORGANIZATION 37 502 7.222e-09 1.623e-07
208 MIDBRAIN DEVELOPMENT 15 90 7.462e-09 1.669e-07
209 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 10 34 7.617e-09 1.696e-07
210 REGULATION OF CYTOPLASMIC TRANSPORT 36 481 7.792e-09 1.727e-07
211 CARDIAC CHAMBER MORPHOGENESIS 16 104 7.83e-09 1.727e-07
212 REGULATION OF ACTIN FILAMENT BASED PROCESS 28 312 8.011e-09 1.758e-07
213 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 23 218 8.65e-09 1.89e-07
214 REGULATION OF CELL CYCLE 55 949 9.675e-09 2.104e-07
215 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 12 55 1.008e-08 2.171e-07
216 POSITIVE REGULATION OF GROWTH 24 238 1.004e-08 2.171e-07
217 REGULATION OF GTPASE ACTIVITY 44 673 1.018e-08 2.183e-07
218 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 19 152 1.089e-08 2.324e-07
219 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 35 465 1.096e-08 2.329e-07
220 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 46 724 1.115e-08 2.358e-07
221 REGULATION OF CELLULAR LOCALIZATION 67 1277 1.131e-08 2.381e-07
222 APPENDAGE DEVELOPMENT 20 169 1.158e-08 2.417e-07
223 LIMB DEVELOPMENT 20 169 1.158e-08 2.417e-07
224 REGULATION OF CELL JUNCTION ASSEMBLY 13 68 1.346e-08 2.797e-07
225 REGULATION OF JUN KINASE ACTIVITY 14 81 1.457e-08 3.014e-07
226 CELL PART MORPHOGENESIS 42 633 1.471e-08 3.029e-07
227 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 25 262 1.513e-08 3.087e-07
228 GASTRULATION 19 155 1.507e-08 3.087e-07
229 DORSAL VENTRAL AXIS SPECIFICATION 8 20 1.555e-08 3.16e-07
230 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 22 207 1.596e-08 3.214e-07
231 POSITIVE REGULATION OF MAP KINASE ACTIVITY 22 207 1.596e-08 3.214e-07
232 REGULATION OF ORGANELLE ORGANIZATION 63 1178 1.606e-08 3.22e-07
233 EPITHELIAL CELL DIFFERENTIATION 36 495 1.638e-08 3.271e-07
234 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 7 14 1.899e-08 3.761e-07
235 CONVERGENT EXTENSION 7 14 1.899e-08 3.761e-07
236 RESPONSE TO DRUG 33 431 1.929e-08 3.803e-07
237 CELL ACTIVATION 39 568 1.968e-08 3.863e-07
238 REGULATION OF TRANSFERASE ACTIVITY 54 946 2.225e-08 4.349e-07
239 REGULATION OF JNK CASCADE 19 159 2.294e-08 4.467e-07
240 REGULATION OF CELL GROWTH 31 391 2.358e-08 4.572e-07
241 ANTERIOR POSTERIOR PATTERN SPECIFICATION 21 194 2.453e-08 4.717e-07
242 CONNECTIVE TISSUE DEVELOPMENT 21 194 2.453e-08 4.717e-07
243 CARDIAC CHAMBER DEVELOPMENT 18 144 2.652e-08 5.079e-07
244 REGULATION OF CELLULAR PROTEIN LOCALIZATION 38 552 2.811e-08 5.36e-07
245 STEM CELL PROLIFERATION 12 60 2.866e-08 5.442e-07
246 REGULATION OF NEURON DEATH 24 252 3.052e-08 5.772e-07
247 REGULATION OF ADHERENS JUNCTION ORGANIZATION 11 50 3.811e-08 7.18e-07
248 SKELETAL SYSTEM MORPHOGENESIS 21 201 4.564e-08 8.562e-07
249 RESPONSE TO WOUNDING 38 563 4.716e-08 8.813e-07
250 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 15 103 4.918e-08 9.153e-07
251 REGULATION OF MAP KINASE ACTIVITY 27 319 5.058e-08 9.376e-07
252 RESPONSE TO ALCOHOL 29 362 5.377e-08 9.928e-07
253 RESPONSE TO HORMONE 51 893 5.553e-08 1.021e-06
254 REGULATION OF PROTEIN BINDING 19 168 5.632e-08 1.028e-06
255 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 15 104 5.615e-08 1.028e-06
256 REGULATION OF CELL MATRIX ADHESION 14 90 5.865e-08 1.066e-06
257 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 7 16 6.057e-08 1.097e-06
258 PROTEIN LOCALIZATION 83 1805 6.665e-08 1.202e-06
259 DORSAL VENTRAL PATTERN FORMATION 14 91 6.773e-08 1.217e-06
260 NEGATIVE REGULATION OF LOCOMOTION 24 263 6.9e-08 1.235e-06
261 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 16 121 7.104e-08 1.266e-06
262 REGULATION OF INTRACELLULAR TRANSPORT 40 621 7.326e-08 1.301e-06
263 NEGATIVE REGULATION OF NEURON DEATH 19 171 7.492e-08 1.325e-06
264 AMEBOIDAL TYPE CELL MIGRATION 18 154 7.578e-08 1.336e-06
265 REGULATION OF SYNAPSE ASSEMBLY 13 79 8.786e-08 1.543e-06
266 REGULATION OF PROTEIN TARGETING 26 307 8.854e-08 1.549e-06
267 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 10 43 9.075e-08 1.581e-06
268 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 18 156 9.25e-08 1.606e-06
269 POSITIVE REGULATION OF TRANSPORT 52 936 9.834e-08 1.701e-06
270 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 12 67 1.045e-07 1.802e-06
271 COGNITION 23 251 1.201e-07 2.062e-06
272 MUSCLE ORGAN DEVELOPMENT 24 277 1.824e-07 3.121e-06
273 REGULATION OF APOPTOTIC SIGNALING PATHWAY 28 363 2.006e-07 3.418e-06
274 CARDIAC SEPTUM DEVELOPMENT 13 85 2.141e-07 3.637e-06
275 NEGATIVE REGULATION OF BINDING 16 131 2.178e-07 3.684e-06
276 NEPHRON DEVELOPMENT 15 115 2.185e-07 3.684e-06
277 REGULATION OF MEMBRANE POTENTIAL 27 343 2.213e-07 3.717e-06
278 MODULATION OF SYNAPTIC TRANSMISSION 25 301 2.275e-07 3.807e-06
279 AXIS ELONGATION 8 27 2.344e-07 3.909e-06
280 REGULATION OF EPITHELIAL CELL MIGRATION 18 166 2.388e-07 3.969e-06
281 NEGATIVE REGULATION OF TRANSPORT 32 458 2.586e-07 4.283e-06
282 SINGLE ORGANISM CELL ADHESION 32 459 2.716e-07 4.481e-06
283 MESODERM DEVELOPMENT 15 118 3.076e-07 5.057e-06
284 IMMUNE SYSTEM DEVELOPMENT 37 582 3.174e-07 5.2e-06
285 REGULATION OF STEM CELL PROLIFERATION 13 88 3.247e-07 5.302e-06
286 CELL DEATH 53 1001 3.356e-07 5.46e-06
287 CARDIAC SEPTUM MORPHOGENESIS 10 49 3.394e-07 5.502e-06
288 IN UTERO EMBRYONIC DEVELOPMENT 25 311 4.212e-07 6.804e-06
289 AXIS SPECIFICATION 13 90 4.245e-07 6.834e-06
290 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 15 121 4.283e-07 6.872e-06
291 STRIATED MUSCLE CELL DIFFERENTIATION 18 173 4.44e-07 7.052e-06
292 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 35 541 4.436e-07 7.052e-06
293 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 35 541 4.436e-07 7.052e-06
294 POSITIVE REGULATION OF JUN KINASE ACTIVITY 11 63 4.667e-07 7.362e-06
295 SKIN DEVELOPMENT 20 211 4.668e-07 7.362e-06
296 REGULATION OF FAT CELL DIFFERENTIATION 14 106 4.736e-07 7.445e-06
297 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 21 232 5.209e-07 8.161e-06
298 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 28 381 5.364e-07 8.375e-06
299 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 7 21 5.514e-07 8.581e-06
300 REGULATION OF VASCULATURE DEVELOPMENT 21 233 5.593e-07 8.674e-06
301 RENAL TUBULE DEVELOPMENT 12 78 5.88e-07 9.09e-06
302 EAR DEVELOPMENT 19 195 5.916e-07 9.115e-06
303 MUSCLE TISSUE DEVELOPMENT 23 275 6.132e-07 9.417e-06
304 NEPHRON EPITHELIUM DEVELOPMENT 13 93 6.256e-07 9.575e-06
305 RESPONSE TO NITROGEN COMPOUND 47 859 6.504e-07 9.922e-06
306 NEGATIVE REGULATION OF GROWTH 21 236 6.903e-07 1.05e-05
307 RESPONSE TO INORGANIC SUBSTANCE 32 479 6.964e-07 1.055e-05
308 FORMATION OF PRIMARY GERM LAYER 14 110 7.503e-07 1.134e-05
309 RESPONSE TO EXTERNAL STIMULUS 80 1821 7.723e-07 1.163e-05
310 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 7 22 7.912e-07 1.176e-05
311 SOMATIC STEM CELL DIVISION 7 22 7.912e-07 1.176e-05
312 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 7 22 7.912e-07 1.176e-05
313 ACTIVATION OF PROTEIN KINASE ACTIVITY 23 279 7.892e-07 1.176e-05
314 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 16 144 8e-07 1.186e-05
315 POSITIVE REGULATION OF BINDING 15 127 8.052e-07 1.189e-05
316 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 25 323 8.502e-07 1.252e-05
317 METANEPHROS DEVELOPMENT 12 81 8.938e-07 1.308e-05
318 MUSCLE CELL DEVELOPMENT 15 128 8.912e-07 1.308e-05
319 LEUKOCYTE ACTIVATION 29 414 9.003e-07 1.313e-05
320 CARDIOCYTE DIFFERENTIATION 13 96 9.078e-07 1.32e-05
321 CELL CELL ADHESION 37 608 9.132e-07 1.324e-05
322 KIDNEY MORPHOGENESIS 12 82 1.023e-06 1.479e-05
323 BETA CATENIN TCF COMPLEX ASSEMBLY 9 43 1.055e-06 1.519e-05
324 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 37 616 1.246e-06 1.789e-05
325 EMBRYONIC AXIS SPECIFICATION 8 33 1.282e-06 1.83e-05
326 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 8 33 1.282e-06 1.83e-05
327 CELLULAR RESPONSE TO ALCOHOL 14 115 1.295e-06 1.843e-05
328 REGULATION OF ION TRANSPORT 36 592 1.308e-06 1.856e-05
329 NEGATIVE REGULATION OF PHOSPHORYLATION 29 422 1.325e-06 1.874e-05
330 REGULATION OF AXONOGENESIS 17 168 1.368e-06 1.928e-05
331 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 15 133 1.458e-06 2.049e-05
332 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 10 57 1.487e-06 2.084e-05
333 RESPONSE TO ABIOTIC STIMULUS 52 1024 1.522e-06 2.126e-05
334 RESPONSE TO STEROID HORMONE 32 497 1.544e-06 2.151e-05
335 NEGATIVE REGULATION OF CELL GROWTH 17 170 1.613e-06 2.239e-05
336 SKIN EPIDERMIS DEVELOPMENT 11 71 1.617e-06 2.239e-05
337 HEART VALVE DEVELOPMENT 8 34 1.64e-06 2.251e-05
338 REGULATION OF EXTENT OF CELL GROWTH 13 101 1.636e-06 2.251e-05
339 BRAIN MORPHOGENESIS 8 34 1.64e-06 2.251e-05
340 LEUKOCYTE DIFFERENTIATION 23 292 1.731e-06 2.368e-05
341 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 15 135 1.763e-06 2.392e-05
342 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 15 135 1.763e-06 2.392e-05
343 EMBRYONIC PATTERN SPECIFICATION 10 58 1.757e-06 2.392e-05
344 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 13 102 1.832e-06 2.478e-05
345 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 18 191 1.895e-06 2.555e-05
346 PEPTIDYL THREONINE MODIFICATION 9 46 1.926e-06 2.582e-05
347 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 36 602 1.925e-06 2.582e-05
348 EYE MORPHOGENESIS 15 136 1.936e-06 2.589e-05
349 CELLULAR RESPONSE TO HORMONE STIMULUS 34 552 1.955e-06 2.606e-05
350 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 14 119 1.961e-06 2.608e-05
351 REGULATION OF MUSCLE TISSUE DEVELOPMENT 13 103 2.049e-06 2.709e-05
352 REGULATION OF MUSCLE ORGAN DEVELOPMENT 13 103 2.049e-06 2.709e-05
353 CELLULAR RESPONSE TO NITROGEN COMPOUND 32 505 2.168e-06 2.858e-05
354 NEGATIVE REGULATION OF CELL CYCLE 29 433 2.214e-06 2.91e-05
355 POSITIVE REGULATION OF PROTEIN IMPORT 13 104 2.288e-06 2.999e-05
356 CHONDROCYTE DIFFERENTIATION 10 60 2.426e-06 3.17e-05
357 SYSTEM PROCESS 77 1785 2.565e-06 3.343e-05
358 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 14 122 2.647e-06 3.44e-05
359 CALCIUM MEDIATED SIGNALING 12 90 2.816e-06 3.638e-05
360 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 11 75 2.823e-06 3.638e-05
361 MESONEPHROS DEVELOPMENT 12 90 2.816e-06 3.638e-05
362 MEMBRANE DEPOLARIZATION 10 61 2.836e-06 3.644e-05
363 CARDIAC VENTRICLE DEVELOPMENT 13 106 2.843e-06 3.644e-05
364 REGULATION OF MUSCLE HYPERTROPHY 8 37 3.262e-06 4.169e-05
365 SOMITOGENESIS 10 62 3.306e-06 4.214e-05
366 INNER EAR MORPHOGENESIS 12 92 3.563e-06 4.53e-05
367 REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 27 3.69e-06 4.654e-05
368 REGULATION OF BMP SIGNALING PATHWAY 11 77 3.679e-06 4.654e-05
369 INOSITOL PHOSPHATE MEDIATED SIGNALING 6 18 3.69e-06 4.654e-05
370 REGULATION OF CARTILAGE DEVELOPMENT 10 63 3.841e-06 4.818e-05
371 REGULATION OF EPIDERMIS DEVELOPMENT 10 63 3.841e-06 4.818e-05
372 WOUND HEALING 30 470 3.907e-06 4.887e-05
373 CELLULAR RESPONSE TO ABIOTIC STIMULUS 21 263 3.931e-06 4.904e-05
374 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 53 1087 3.956e-06 4.922e-05
375 MESENCHYME MORPHOGENESIS 8 38 4.04e-06 5.013e-05
376 NEURON MIGRATION 13 110 4.32e-06 5.346e-05
377 ACTIN FILAMENT BASED PROCESS 29 450 4.706e-06 5.793e-05
378 SEX DIFFERENTIATION 21 266 4.695e-06 5.793e-05
379 NEGATIVE REGULATION OF PROTEIN BINDING 11 79 4.754e-06 5.836e-05
380 DOPAMINERGIC NEURON DIFFERENTIATION 7 28 4.814e-06 5.894e-05
381 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 8 39 4.971e-06 6.055e-05
382 NEGATIVE CHEMOTAXIS 8 39 4.971e-06 6.055e-05
383 FOREBRAIN DEVELOPMENT 25 357 5.128e-06 6.224e-05
384 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 14 129 5.137e-06 6.224e-05
385 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 6 19 5.279e-06 6.373e-05
386 EAR MORPHOGENESIS 13 112 5.287e-06 6.373e-05
387 REGULATION OF HORMONE LEVELS 30 478 5.458e-06 6.563e-05
388 POSITIVE REGULATION OF CELL GROWTH 15 148 5.576e-06 6.687e-05
389 LENS DEVELOPMENT IN CAMERA TYPE EYE 10 66 5.925e-06 7.087e-05
390 REGULATION OF FIBROBLAST PROLIFERATION 11 81 6.093e-06 7.27e-05
391 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 19 228 6.11e-06 7.272e-05
392 STEM CELL DIVISION 7 29 6.207e-06 7.349e-05
393 REGULATION OF HEART MORPHOGENESIS 7 29 6.207e-06 7.349e-05
394 RESPONSE TO CYTOKINE 39 714 6.301e-06 7.441e-05
395 REGULATION OF ENDOTHELIAL CELL MIGRATION 13 114 6.44e-06 7.586e-05
396 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 9 53 6.618e-06 7.776e-05
397 CELLULAR RESPONSE TO DRUG 10 67 6.808e-06 7.98e-05
398 CARTILAGE MORPHOGENESIS 5 12 7.016e-06 8.182e-05
399 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 5 12 7.016e-06 8.182e-05
400 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 17 190 7.339e-06 8.537e-05
401 TONGUE DEVELOPMENT 6 20 7.38e-06 8.542e-05
402 POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 6 20 7.38e-06 8.542e-05
403 LYMPHOCYTE ACTIVATION 24 342 7.631e-06 8.811e-05
404 HAIR CYCLE 11 83 7.751e-06 8.883e-05
405 REGULATION OF MUSCLE CELL DIFFERENTIATION 15 152 7.736e-06 8.883e-05
406 MOLTING CYCLE 11 83 7.751e-06 8.883e-05
407 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 7 30 7.92e-06 9.055e-05
408 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 15 153 8.381e-06 9.558e-05
409 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 12 100 8.588e-06 9.77e-05
410 LEUKOCYTE CELL CELL ADHESION 20 255 8.691e-06 9.863e-05
411 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 11 84 8.718e-06 9.87e-05
412 EPITHELIAL CELL MORPHOGENESIS 8 42 8.921e-06 0.0001005
413 POSITIVE REGULATION OF AXONOGENESIS 10 69 8.922e-06 0.0001005
414 REGULATION OF KIDNEY DEVELOPMENT 9 55 9.078e-06 0.000102
415 CAMERA TYPE EYE MORPHOGENESIS 12 101 9.526e-06 0.0001068
416 GLAND DEVELOPMENT 26 395 1.007e-05 0.0001127
417 NEURAL PRECURSOR CELL PROLIFERATION 10 70 1.018e-05 0.0001135
418 REGULATION OF MUSCLE SYSTEM PROCESS 17 195 1.036e-05 0.0001153
419 BONE DEVELOPMENT 15 156 1.061e-05 0.0001178
420 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 18 216 1.069e-05 0.0001184
421 REGULATION OF CELL FATE SPECIFICATION 5 13 1.116e-05 0.0001231
422 GANGLION DEVELOPMENT 5 13 1.116e-05 0.0001231
423 EXTRACELLULAR STRUCTURE ORGANIZATION 22 304 1.127e-05 0.0001239
424 REGULATION OF DENDRITE DEVELOPMENT 13 120 1.134e-05 0.0001244
425 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 21 282 1.154e-05 0.0001264
426 ENDOCARDIAL CUSHION DEVELOPMENT 7 32 1.253e-05 0.0001366
427 PATTERNING OF BLOOD VESSELS 7 32 1.253e-05 0.0001366
428 REGULATION OF SYNAPTIC PLASTICITY 14 140 1.33e-05 0.0001446
429 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 6 22 1.361e-05 0.0001476
430 CEREBRAL CORTEX DEVELOPMENT 12 105 1.423e-05 0.0001536
431 ODONTOGENESIS 12 105 1.423e-05 0.0001536
432 SECOND MESSENGER MEDIATED SIGNALING 15 160 1.44e-05 0.000155
433 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 14 141 1.443e-05 0.000155
434 POSITIVE REGULATION OF PROTEIN BINDING 10 73 1.489e-05 0.0001597
435 RESPONSE TO METAL ION 23 333 1.521e-05 0.0001627
436 VASCULOGENESIS 9 59 1.64e-05 0.000175
437 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 9 60 1.886e-05 0.0002009
438 REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 34 1.917e-05 0.0002037
439 OSTEOBLAST DIFFERENTIATION 13 126 1.926e-05 0.0002041
440 POSITIVE REGULATION OF STEM CELL PROLIFERATION 9 61 2.164e-05 0.0002288
441 EPITHELIAL CELL DEVELOPMENT 16 186 2.216e-05 0.0002338
442 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 15 166 2.233e-05 0.000234
443 REGULATION OF CELL DIVISION 20 272 2.231e-05 0.000234
444 TELENCEPHALON DEVELOPMENT 18 228 2.225e-05 0.000234
445 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 6 24 2.351e-05 0.0002453
446 RESPONSE TO STEROL 6 24 2.351e-05 0.0002453
447 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 45 926 2.388e-05 0.000248
448 OSSIFICATION 19 251 2.386e-05 0.000248
449 MESENCHYMAL TO EPITHELIAL TRANSITION 5 15 2.497e-05 0.0002562
450 PEPTIDYL SERINE MODIFICATION 14 148 2.5e-05 0.0002562
451 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 5 15 2.497e-05 0.0002562
452 REGULATION OF CATABOLIC PROCESS 38 731 2.497e-05 0.0002562
453 REGULATION OF SMOOTHENED SIGNALING PATHWAY 9 62 2.475e-05 0.0002562
454 CELLULAR RESPONSE TO STEROL 5 15 2.497e-05 0.0002562
455 LYMPHOCYTE DIFFERENTIATION 17 209 2.556e-05 0.0002614
456 POSITIVE REGULATION OF CYTOKINE PRODUCTION 24 370 2.79e-05 0.0002847
457 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 11 95 2.853e-05 0.0002899
458 HEAD MORPHOGENESIS 7 36 2.847e-05 0.0002899
459 POSITIVE REGULATION OF CATABOLIC PROCESS 25 395 2.869e-05 0.0002909
460 OVULATION CYCLE 12 113 3.001e-05 0.0003036
461 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 6 25 3.027e-05 0.0003056
462 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 29 498 3.152e-05 0.0003175
463 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 15 171 3.166e-05 0.0003182
464 REGULATION OF PHOSPHOLIPASE ACTIVITY 9 64 3.213e-05 0.0003222
465 CELLULAR MACROMOLECULE LOCALIZATION 55 1234 3.353e-05 0.0003355
466 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 8 50 3.397e-05 0.0003377
467 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 8 50 3.397e-05 0.0003377
468 RHO PROTEIN SIGNAL TRANSDUCTION 8 50 3.397e-05 0.0003377
469 SYNAPTIC SIGNALING 26 424 3.413e-05 0.0003386
470 MYOBLAST DIFFERENTIATION 7 37 3.435e-05 0.0003401
471 PARAXIAL MESODERM DEVELOPMENT 5 16 3.557e-05 0.0003507
472 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 5 16 3.557e-05 0.0003507
473 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 12 115 3.578e-05 0.0003512
474 RESPONSE TO CALCIUM ION 12 115 3.578e-05 0.0003512
475 POSITIVE REGULATION OF CELL ADHESION 24 376 3.61e-05 0.0003537
476 PALLIUM DEVELOPMENT 14 153 3.624e-05 0.0003543
477 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 23 352 3.645e-05 0.0003556
478 REGULATION OF MESONEPHROS DEVELOPMENT 6 26 3.852e-05 0.0003749
479 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 8 51 3.941e-05 0.0003828
480 COLLAGEN FIBRIL ORGANIZATION 7 38 4.12e-05 0.0003985
481 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 7 38 4.12e-05 0.0003985
482 MESODERM MORPHOGENESIS 9 66 4.129e-05 0.0003986
483 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 17 218 4.369e-05 0.0004209
484 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 14 156 4.493e-05 0.0004319
485 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 12 118 4.622e-05 0.0004434
486 REGULATION OF LIPASE ACTIVITY 10 83 4.651e-05 0.0004453
487 HINDBRAIN DEVELOPMENT 13 137 4.684e-05 0.0004475
488 CYTOSKELETON ORGANIZATION 41 838 4.771e-05 0.0004544
489 REGULATION OF IMMUNE SYSTEM PROCESS 60 1403 4.776e-05 0.0004544
490 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 27 4.847e-05 0.0004602
491 REGULATION OF CHROMATIN BINDING 5 17 4.934e-05 0.0004667
492 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 17 4.934e-05 0.0004667
493 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 13 138 5.054e-05 0.000476
494 PLACENTA DEVELOPMENT 13 138 5.054e-05 0.000476
495 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 10 84 5.161e-05 0.0004852
496 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 8 53 5.247e-05 0.0004912
497 MESONEPHRIC TUBULE MORPHOGENESIS 8 53 5.247e-05 0.0004912
498 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 29 514 5.561e-05 0.0005196
499 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 26 437 5.65e-05 0.0005269
500 CHEMICAL HOMEOSTASIS 42 874 5.787e-05 0.0005385
501 CARDIAC MUSCLE TISSUE DEVELOPMENT 13 140 5.871e-05 0.0005452
502 VENTRICULAR SEPTUM MORPHOGENESIS 6 28 6.037e-05 0.0005574
503 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 6 28 6.037e-05 0.0005574
504 VENTRICULAR SEPTUM DEVELOPMENT 8 54 6.025e-05 0.0005574
505 REGULATION OF DNA METABOLIC PROCESS 22 340 6.195e-05 0.0005708
506 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 12 122 6.419e-05 0.0005902
507 RESPONSE TO KETONE 15 182 6.508e-05 0.0005972
508 REPRODUCTION 56 1297 6.734e-05 0.0006168
509 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 31 573 6.776e-05 0.0006195
510 FC EPSILON RECEPTOR SIGNALING PATHWAY 13 142 6.8e-05 0.0006204
511 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 7 41 6.873e-05 0.0006254
512 CRANIAL SKELETAL SYSTEM DEVELOPMENT 8 55 6.896e-05 0.0006254
513 REGULATION OF MITOTIC CELL CYCLE 27 468 6.885e-05 0.0006254
514 MULTICELLULAR ORGANISMAL SIGNALING 12 123 6.952e-05 0.0006281
515 T CELL DIFFERENTIATION 12 123 6.952e-05 0.0006281
516 ESTABLISHMENT OF PROTEIN LOCALIZATION 60 1423 7.112e-05 0.0006413
517 EPIDERMIS MORPHOGENESIS 6 29 7.45e-05 0.0006666
518 CARDIAC MUSCLE CELL CONTRACTION 6 29 7.45e-05 0.0006666
519 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING 9 71 7.428e-05 0.0006666
520 CELL FATE SPECIFICATION 9 71 7.428e-05 0.0006666
521 OVULATION CYCLE PROCESS 10 88 7.71e-05 0.0006885
522 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 23 370 7.814e-05 0.0006965
523 SMAD PROTEIN SIGNAL TRANSDUCTION 8 56 7.869e-05 0.0006974
524 REGULATION OF DENDRITIC SPINE DEVELOPMENT 8 56 7.869e-05 0.0006974
525 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 19 274 7.846e-05 0.0006974
526 FAT CELL DIFFERENTIATION 11 106 7.913e-05 7e-04
527 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 7 42 8.069e-05 0.0007111
528 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 7 42 8.069e-05 0.0007111
529 ENDOTHELIAL CELL DIFFERENTIATION 9 72 8.301e-05 0.0007302
530 EPITHELIAL CELL PROLIFERATION 10 89 8.492e-05 0.0007441
531 POST EMBRYONIC DEVELOPMENT 10 89 8.492e-05 0.0007441
532 MYOTUBE DIFFERENTIATION 8 57 8.953e-05 0.000783
533 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 6 30 9.115e-05 0.0007957
534 EMBRYONIC HEART TUBE DEVELOPMENT 9 73 9.259e-05 0.0008053
535 REGULATION OF ORGAN GROWTH 9 73 9.259e-05 0.0008053
536 ENDOTHELIUM DEVELOPMENT 10 90 9.341e-05 0.0008109
537 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 43 9.43e-05 0.0008155
538 MORPHOGENESIS OF AN EPITHELIAL SHEET 7 43 9.43e-05 0.0008155
539 NEGATIVE REGULATION OF ION TRANSPORT 12 127 9.486e-05 0.0008189
540 REGULATION OF PEPTIDE TRANSPORT 18 256 0.0001009 0.0008691
541 REGULATION OF DENDRITE MORPHOGENESIS 9 74 0.0001031 0.0008849
542 ACTIN MEDIATED CELL CONTRACTION 9 74 0.0001031 0.0008849
543 SECRETION 31 588 0.0001084 0.0009291
544 BODY MORPHOGENESIS 7 44 0.0001097 0.0009384
545 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 6 31 0.0001106 0.0009444
546 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 16 213 0.0001131 0.0009639
547 MUSCLE SYSTEM PROCESS 19 282 0.0001146 0.0009752
548 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 5 20 0.0001161 0.0009839
549 TRACHEA DEVELOPMENT 5 20 0.0001161 0.0009839
550 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 11 0.0001169 0.0009888
551 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 10 93 0.0001233 0.001039
552 REGULATION OF DNA BINDING 10 93 0.0001233 0.001039
553 POSITIVE REGULATION OF CELL CYCLE 21 332 0.0001244 0.001047
554 LUNG MORPHOGENESIS 7 45 0.0001271 0.001068
555 SECRETION BY CELL 27 486 0.0001287 0.001079
556 REGULATION OF CELL SIZE 14 172 0.0001292 0.001081
557 REGULATION OF HORMONE SECRETION 18 262 0.0001351 0.001122
558 ACTION POTENTIAL 10 94 0.0001349 0.001122
559 RESPONSE TO BMP 10 94 0.0001349 0.001122
560 CELLULAR RESPONSE TO BMP STIMULUS 10 94 0.0001349 0.001122
561 MAINTENANCE OF CELL NUMBER 12 132 0.0001374 0.001139
562 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 9 77 0.0001407 0.001165
563 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 22 360 0.000142 0.001174
564 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 8 61 0.000146 0.001205
565 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 7 46 0.0001467 0.001208
566 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 10 95 0.0001474 0.001212
567 HOMEOSTATIC PROCESS 56 1337 0.0001495 0.001227
568 REGULATION OF CELLULAR COMPONENT SIZE 21 337 0.0001531 0.001254
569 PROTEIN COMPLEX SUBUNIT ORGANIZATION 62 1527 0.0001543 0.001262
570 NEGATIVE REGULATION OF ANION TRANSPORT 6 33 0.0001594 0.001301
571 MYELOID LEUKOCYTE DIFFERENTIATION 10 96 0.0001609 0.001311
572 CARDIAC VENTRICLE MORPHOGENESIS 8 62 0.000164 0.001329
573 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 8 62 0.000164 0.001329
574 EMBRYONIC HEART TUBE MORPHOGENESIS 8 62 0.000164 0.001329
575 REGULATION OF MICROTUBULE BASED PROCESS 17 243 0.0001658 0.001342
576 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 7 47 0.0001686 0.001362
577 DENDRITE DEVELOPMENT 9 79 0.0001717 0.001381
578 CELLULAR RESPONSE TO CHOLESTEROL 4 12 0.0001718 0.001381
579 TRACHEA MORPHOGENESIS 4 12 0.0001718 0.001381
580 REGULATION OF HAIR CYCLE 5 22 0.0001891 0.001514
581 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 5 22 0.0001891 0.001514
582 NEURAL TUBE PATTERNING 6 34 0.0001895 0.001515
583 MEMORY 10 98 0.000191 0.001519
584 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 10 98 0.000191 0.001519
585 REGULATION OF PROTEIN CATABOLIC PROCESS 23 393 0.0001905 0.001519
586 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 48 0.0001932 0.001534
587 REGULATION OF ANATOMICAL STRUCTURE SIZE 26 472 0.0001953 0.001543
588 SKELETAL MUSCLE ORGAN DEVELOPMENT 12 137 0.0001953 0.001543
589 CELLULAR RESPONSE TO RADIATION 12 137 0.0001953 0.001543
590 REGULATED EXOCYTOSIS 16 224 0.0002021 0.001594
591 REGULATION OF BLOOD CIRCULATION 19 295 0.0002052 0.001615
592 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 10 99 0.0002077 0.00163
593 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 10 99 0.0002077 0.00163
594 POSITIVE REGULATION OF SECRETION 22 370 0.0002092 0.001639
595 CELLULAR RESPONSE TO CALCIUM ION 7 49 0.0002205 0.001724
596 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 10 100 0.0002257 0.001762
597 REGULATION OF CELL CYCLE PROCESS 29 558 0.0002286 0.001782
598 NEGATIVE REGULATION OF AXONOGENESIS 8 65 0.0002291 0.001783
599 REGULATION OF SECRETION 34 699 0.0002356 0.00183
600 REGULATION OF OSTEOBLAST PROLIFERATION 5 23 0.0002366 0.001835
601 HEMATOPOIETIC STEM CELL PROLIFERATION 4 13 0.0002432 0.001877
602 REGULATION OF SKELETAL MUSCLE ADAPTATION 4 13 0.0002432 0.001877
603 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 4 13 0.0002432 0.001877
604 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 10 101 0.0002449 0.001887
605 PROTEOGLYCAN METABOLIC PROCESS 9 83 0.0002507 0.001923
606 FACE DEVELOPMENT 7 50 0.0002509 0.001923
607 ENDODERM FORMATION 7 50 0.0002509 0.001923
608 CELLULAR RESPONSE TO UV 8 66 0.000255 0.001949
609 POSITIVE REGULATION OF LIPASE ACTIVITY 8 66 0.000255 0.001949
610 NEUROLOGICAL SYSTEM PROCESS 52 1242 0.0002626 0.001999
611 POSITIVE REGULATION OF AXON EXTENSION 6 36 0.0002629 0.001999
612 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 6 36 0.0002629 0.001999
613 REGULATION OF CYTOKINE PRODUCTION 29 563 0.0002651 0.002012
614 EPIDERMIS DEVELOPMENT 17 253 0.0002672 0.002025
615 POSITIVE REGULATION OF DNA METABOLIC PROCESS 14 185 0.0002766 0.002092
616 NEURAL CREST CELL MIGRATION 7 51 0.0002845 0.002149
617 REGULATION OF CIRCADIAN RHYTHM 10 103 0.0002875 0.002168
618 RAS PROTEIN SIGNAL TRANSDUCTION 12 143 0.0002911 0.002192
619 REGULATION OF PEPTIDE SECRETION 15 209 0.0003009 0.002262
620 ORGAN GROWTH 8 68 0.0003141 0.002353
621 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 68 0.0003141 0.002353
622 POSITIVE REGULATION OF DNA REPLICATION 9 86 0.0003281 0.002454
623 POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION 4 14 0.0003337 0.00248
624 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 38 829 0.0003336 0.00248
625 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 4 14 0.0003337 0.00248
626 MIDGUT DEVELOPMENT 4 14 0.0003337 0.00248
627 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 17 258 0.0003356 0.002491
628 SYNAPSE ASSEMBLY 8 69 0.0003475 0.002575
629 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 5 25 0.0003583 0.002638
630 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 25 0.0003583 0.002638
631 POSITIVE REGULATION OF ORGAN GROWTH 6 38 0.000357 0.002638
632 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 0.0003583 0.002638
633 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 7 53 0.0003627 0.002662
634 MAMMARY GLAND EPITHELIUM DEVELOPMENT 7 53 0.0003627 0.002662
635 MUSCLE ORGAN MORPHOGENESIS 8 70 0.0003838 0.002812
636 REGULATION OF RESPONSE TO WOUNDING 23 413 0.0003863 0.002826
637 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 22 387 0.000389 0.002842
638 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 9 88 0.0003899 0.002843
639 MALE SEX DIFFERENTIATION 12 148 0.000399 0.002905
640 RESPONSE TO EXTRACELLULAR STIMULUS 24 441 0.0004055 0.002948
641 REGULATION OF PHOSPHOLIPASE C ACTIVITY 6 39 0.0004129 0.002993
642 COCHLEA DEVELOPMENT 6 39 0.0004129 0.002993
643 REGULATION OF PROTEIN SECRETION 22 389 0.0004172 0.003019
644 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 17 263 0.0004187 0.003025
645 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 8 71 0.0004231 0.003043
646 ENDODERM DEVELOPMENT 8 71 0.0004231 0.003043
647 CELL CYCLE PROCESS 46 1081 0.0004229 0.003043
648 REGULATION OF MACROPHAGE ACTIVATION 5 26 0.0004344 0.00311
649 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 5 26 0.0004344 0.00311
650 REGULATION OF CELL FATE COMMITMENT 5 26 0.0004344 0.00311
651 REGULATION OF HAIR FOLLICLE DEVELOPMENT 4 15 0.000446 0.003178
652 REGULATION OF MESODERM DEVELOPMENT 4 15 0.000446 0.003178
653 BLASTODERM SEGMENTATION 4 15 0.000446 0.003178
654 REGULATION OF REPRODUCTIVE PROCESS 11 129 0.0004499 0.003201
655 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 7 55 0.0004571 0.003247
656 IMMUNE SYSTEM PROCESS 74 1984 0.0004593 0.003258
657 RESPONSE TO ESTROGEN 15 218 0.0004706 0.003333
658 FORELIMB MORPHOGENESIS 6 40 0.0004755 0.003363
659 PROTEIN LOCALIZATION TO CELL PERIPHERY 12 151 0.0004786 0.003379
660 LEARNING 11 131 0.0005128 0.00361
661 RETINA DEVELOPMENT IN CAMERA TYPE EYE 11 131 0.0005128 0.00361
662 HIPPO SIGNALING 5 27 0.0005221 0.003664
663 EXCITATORY POSTSYNAPTIC POTENTIAL 5 27 0.0005221 0.003664
664 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 10 111 0.0005248 0.003678
665 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 6 41 0.0005453 0.003809
666 LUNG ALVEOLUS DEVELOPMENT 6 41 0.0005453 0.003809
667 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 22 397 0.0005487 0.003827
668 CELL CYCLE ARREST 12 154 0.0005713 0.003979
669 CELL CYCLE 53 1316 0.0005747 0.003997
670 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 4 16 0.0005828 0.004047
671 ACTIN FILAMENT BASED MOVEMENT 9 93 0.0005872 0.004072
672 REGULATION OF TRANSMEMBRANE TRANSPORT 23 426 0.0005931 0.004107
673 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 14 200 0.0006073 0.004198
674 GASTRULATION WITH MOUTH FORMING SECOND 5 28 0.0006225 0.004285
675 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 28 0.0006225 0.004285
676 REGULATION OF NEUROBLAST PROLIFERATION 5 28 0.0006225 0.004285
677 PROTEIN LOCALIZATION TO NUCLEUS 12 156 0.000641 0.004406
678 POSITIVE REGULATION OF ENDOCYTOSIS 10 114 0.0006479 0.004447
679 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 11 135 0.0006609 0.004529
680 REGULATION OF CELL ACTIVATION 25 484 0.000664 0.004543
681 REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 6 43 0.0007084 0.004826
682 CELL FATE DETERMINATION 6 43 0.0007084 0.004826
683 CEREBRAL CORTEX CELL MIGRATION 6 43 0.0007084 0.004826
684 ACTOMYOSIN STRUCTURE ORGANIZATION 8 77 0.0007332 0.004987
685 NEUROBLAST PROLIFERATION 5 29 0.0007367 0.005004
686 REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 4 17 0.0007469 0.005032
687 ESTABLISHMENT OF TISSUE POLARITY 4 17 0.0007469 0.005032
688 REGULATION OF PROTEIN KINASE A SIGNALING 4 17 0.0007469 0.005032
689 REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE 4 17 0.0007469 0.005032
690 FEMALE SEX DIFFERENTIATION 10 116 0.0007425 0.005032
691 ACTIVATION OF MAPK ACTIVITY 11 137 0.0007473 0.005032
692 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 7 60 0.0007803 0.005247
693 REGULATION OF CHROMOSOME ORGANIZATION 17 278 0.0007828 0.005256
694 SINGLE ORGANISM CELLULAR LOCALIZATION 39 898 0.0007908 0.005302
695 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 10 117 0.0007939 0.005315
696 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 8 78 0.0007992 0.005343
697 LABYRINTHINE LAYER DEVELOPMENT 6 44 0.0008029 0.005352
698 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 6 44 0.0008029 0.005352
699 REGULATION OF LEUKOCYTE PROLIFERATION 14 206 0.0008119 0.005397
700 FC RECEPTOR SIGNALING PATHWAY 14 206 0.0008119 0.005397
701 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 9 98 0.0008597 0.005706
702 EMBRYONIC DIGIT MORPHOGENESIS 7 61 0.0008626 0.005717
703 MYOTUBE CELL DEVELOPMENT 5 30 0.0008658 0.005722
704 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 5 30 0.0008658 0.005722
705 BONE MORPHOGENESIS 8 79 0.0008699 0.005741
706 THYMOCYTE AGGREGATION 6 45 0.0009069 0.005956
707 CELL JUNCTION ORGANIZATION 13 185 0.0009075 0.005956
708 SPROUTING ANGIOGENESIS 6 45 0.0009069 0.005956
709 T CELL DIFFERENTIATION IN THYMUS 6 45 0.0009069 0.005956
710 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 9 99 0.0009249 0.006061
711 REGULATION OF COLLATERAL SPROUTING 4 18 0.0009412 0.006108
712 RETINAL GANGLION CELL AXON GUIDANCE 4 18 0.0009412 0.006108
713 MUSCLE CONTRACTION 15 233 0.0009347 0.006108
714 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 14 209 0.0009343 0.006108
715 PHARYNGEAL SYSTEM DEVELOPMENT 4 18 0.0009412 0.006108
716 POST ANAL TAIL MORPHOGENESIS 4 18 0.0009412 0.006108
717 UTERUS DEVELOPMENT 4 18 0.0009412 0.006108
718 FOREBRAIN CELL MIGRATION 7 62 0.0009515 0.006166
719 RESPONSE TO MECHANICAL STIMULUS 14 210 0.0009785 0.006332
720 METENCEPHALON DEVELOPMENT 9 100 0.000994 0.006424
721 EXOCYTOSIS 18 310 0.001009 0.00651
722 MATERNAL PLACENTA DEVELOPMENT 5 31 0.001011 0.006516
723 REGULATION OF CHONDROCYTE DIFFERENTIATION 6 46 0.001021 0.00657
724 RESPONSE TO OXYGEN LEVELS 18 311 0.001046 0.006722
725 NEUROEPITHELIAL CELL DIFFERENTIATION 7 63 0.001047 0.006722
726 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 11 143 0.001065 0.006824
727 REGULATION OF HOMEOSTATIC PROCESS 23 447 0.001132 0.007244
728 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 6 47 0.001146 0.007322
729 POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 7 64 0.001151 0.007345
730 PROTEIN DEPHOSPHORYLATION 13 190 0.001159 0.007387
731 REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 4 19 0.001168 0.007419
732 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 19 0.001168 0.007419
733 REGULATION OF ORGAN FORMATION 5 32 0.001174 0.007419
734 EMBRYONIC FORELIMB MORPHOGENESIS 5 32 0.001174 0.007419
735 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 5 32 0.001174 0.007419
736 BLOOD VESSEL REMODELING 5 32 0.001174 0.007419
737 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 11 145 0.001192 0.007529
738 EMBRYONIC PLACENTA DEVELOPMENT 8 83 0.001204 0.007594
739 CELL PROJECTION ASSEMBLY 16 264 0.001213 0.007639
740 REGULATION OF IMMUNE RESPONSE 37 858 0.001215 0.00764
741 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 103 0.001227 0.007705
742 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 6 48 0.001282 0.007983
743 REGULATION OF MYOBLAST DIFFERENTIATION 6 48 0.001282 0.007983
744 MYOFIBRIL ASSEMBLY 6 48 0.001282 0.007983
745 ANTERIOR POSTERIOR AXIS SPECIFICATION 6 48 0.001282 0.007983
746 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 6 48 0.001282 0.007983
747 PROTEIN AUTOPHOSPHORYLATION 13 192 0.001275 0.007983
748 TISSUE MIGRATION 8 84 0.001302 0.008102
749 REGULATION OF PROTEOLYSIS 32 711 0.001307 0.008117
750 EMBRYONIC EYE MORPHOGENESIS 5 33 0.001355 0.008405
751 SOMATIC STEM CELL POPULATION MAINTENANCE 7 66 0.001382 0.00856
752 RESPONSE TO UV 10 126 0.001402 0.008664
753 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 10 126 0.001402 0.008664
754 EPHRIN RECEPTOR SIGNALING PATHWAY 8 85 0.001406 0.008679
755 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 6 49 0.00143 0.008811
756 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 18 321 0.001491 0.009179
757 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 17 296 0.001549 0.009521
758 PROTEIN DESTABILIZATION 5 34 0.001556 0.009549
759 REGULATION OF HEART CONTRACTION 14 221 0.001591 0.00974
760 NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION 14 221 0.001591 0.00974
761 PEPTIDYL AMINO ACID MODIFICATION 36 841 0.001599 0.009779
762 CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 15 246 0.001606 0.009807
NumGOOverlapSizeP ValueAdj. P Value
1 WNT PROTEIN BINDING 16 31 4.874e-18 4.528e-15
2 WNT ACTIVATED RECEPTOR ACTIVITY 14 22 1.007e-17 4.677e-15
3 FRIZZLED BINDING 16 36 1.054e-16 3.265e-14
4 BETA CATENIN BINDING 19 84 2.441e-13 5.67e-11
5 RECEPTOR BINDING 84 1476 1.699e-12 3.157e-10
6 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 33 328 1.756e-11 2.331e-09
7 ENZYME BINDING 91 1737 1.702e-11 2.331e-09
8 SIGNAL TRANSDUCER ACTIVITY 88 1731 1.864e-10 2.165e-08
9 REGULATORY REGION NUCLEIC ACID BINDING 53 818 3.923e-10 4.049e-08
10 PROTEIN KINASE ACTIVITY 45 640 7.174e-10 6.664e-08
11 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 44 629 1.313e-09 1.109e-07
12 MOLECULAR FUNCTION REGULATOR 72 1353 1.621e-09 1.255e-07
13 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 24 226 3.599e-09 2.572e-07
14 TRANSCRIPTION FACTOR BINDING 38 524 6.985e-09 4.635e-07
15 CYTOKINE BINDING 15 92 1.019e-08 5.917e-07
16 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 28 315 9.88e-09 5.917e-07
17 CORE PROMOTER PROXIMAL REGION DNA BINDING 30 371 2.561e-08 1.4e-06
18 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 63 1199 3.093e-08 1.597e-06
19 PROTEIN SERINE THREONINE KINASE ACTIVITY 33 445 4.15e-08 2.029e-06
20 KINASE ACTIVITY 49 842 5.802e-08 2.695e-06
21 PROTEIN DOMAIN SPECIFIC BINDING 40 624 8.332e-08 3.686e-06
22 SMAD BINDING 12 72 2.387e-07 1.008e-05
23 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 14 104 3.731e-07 1.507e-05
24 SEQUENCE SPECIFIC DNA BINDING 54 1037 4.345e-07 1.682e-05
25 GROWTH FACTOR BINDING 15 123 5.309e-07 1.973e-05
26 MACROMOLECULAR COMPLEX BINDING 66 1399 7.407e-07 2.647e-05
27 KINASE BINDING 37 606 8.441e-07 2.904e-05
28 DOUBLE STRANDED DNA BINDING 43 764 9.553e-07 3.169e-05
29 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 51 992 1.352e-06 4.332e-05
30 RECEPTOR SIGNALING PROTEIN ACTIVITY 17 172 1.897e-06 5.873e-05
31 CALMODULIN BINDING 17 179 3.282e-06 9.834e-05
32 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 11 81 6.093e-06 0.0001769
33 G PROTEIN COUPLED RECEPTOR BINDING 20 259 1.094e-05 0.000305
34 ARMADILLO REPEAT DOMAIN BINDING 5 13 1.116e-05 0.000305
35 GROWTH FACTOR ACTIVITY 15 160 1.44e-05 0.0003822
36 PDZ DOMAIN BINDING 11 90 1.703e-05 0.0004396
37 CELL ADHESION MOLECULE BINDING 16 186 2.216e-05 0.0005563
38 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 15 168 2.572e-05 0.0006288
39 TRANSFORMING GROWTH FACTOR BETA BINDING 5 16 3.557e-05 0.0008261
40 RECEPTOR AGONIST ACTIVITY 5 16 3.557e-05 0.0008261
41 HEPARIN BINDING 14 157 4.821e-05 0.001092
42 CHROMATIN BINDING 26 435 5.237e-05 0.001158
43 ENZYME REGULATOR ACTIVITY 45 959 5.518e-05 0.001192
44 PHOSPHORIC ESTER HYDROLASE ACTIVITY 23 368 7.2e-05 0.001498
45 INTEGRIN BINDING 11 105 7.255e-05 0.001498
46 PROTEIN KINASE A BINDING 7 42 8.069e-05 0.00163
47 ACTIVATING TRANSCRIPTION FACTOR BINDING 8 57 8.953e-05 0.00177
48 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 31 588 0.0001084 0.002099
49 I SMAD BINDING 4 11 0.0001169 0.002172
50 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 5 20 0.0001161 0.002172
51 CYTOSKELETAL PROTEIN BINDING 39 819 0.0001289 0.002259
52 PROTEIN COMPLEX BINDING 43 935 0.0001267 0.002259
53 RECEPTOR REGULATOR ACTIVITY 7 45 0.0001271 0.002259
54 RECEPTOR ACTIVATOR ACTIVITY 6 32 0.0001333 0.002292
55 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 12 133 0.0001476 0.002493
56 RHO GTPASE BINDING 9 78 0.0001555 0.00258
57 GAMMA CATENIN BINDING 4 12 0.0001718 0.0028
58 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 8 64 0.0002054 0.00329
59 CAMP BINDING 5 23 0.0002366 0.003669
60 GLYCOSAMINOGLYCAN BINDING 15 205 0.0002444 0.003669
61 SIGNALING RECEPTOR ACTIVITY 57 1393 0.0002376 0.003669
62 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 10 101 0.0002449 0.003669
63 CYCLIC NUCLEOTIDE BINDING 6 36 0.0002629 0.003876
64 MITOGEN ACTIVATED PROTEIN KINASE BINDING 5 24 0.0002927 0.004249
65 SODIUM CHANNEL ACTIVITY 6 37 0.0003071 0.004389
66 SULFUR COMPOUND BINDING 16 234 0.0003306 0.004592
67 MAP KINASE ACTIVITY 4 14 0.0003337 0.004592
68 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 10 105 0.0003361 0.004592
69 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 4 15 0.000446 0.005919
70 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING 4 15 0.000446 0.005919
71 DRUG BINDING 10 109 0.000454 0.005941
72 PROTEIN DIMERIZATION ACTIVITY 48 1149 0.0004775 0.006161
73 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 9 92 0.0005423 0.006902
74 TRANSCRIPTION COACTIVATOR ACTIVITY 18 296 0.0005923 0.007436
75 ADENYL NUCLEOTIDE BINDING 59 1514 0.000636 0.007877
76 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 8 76 0.0006716 0.008209
77 RECEPTOR ACTIVITY 63 1649 0.0006893 0.008316
78 STEROID HORMONE RECEPTOR ACTIVITY 7 59 0.0007044 0.00839
79 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 15 228 0.0007494 0.008812
80 RIBONUCLEOTIDE BINDING 69 1860 0.0008407 0.009763
NumGOOverlapSizeP ValueAdj. P Value
1 SYNAPSE 57 754 1.63e-13 3.746e-11
2 NEURON PROJECTION 65 942 1.924e-13 3.746e-11
3 CELL PROJECTION 98 1786 1.46e-13 3.746e-11
4 NEURON PART 77 1265 6.026e-13 8.798e-11
5 BETA CATENIN DESTRUCTION COMPLEX 9 14 7.208e-12 8.419e-10
6 WNT SIGNALOSOME 8 11 2.492e-11 2.426e-09
7 SYNAPSE PART 46 610 4.566e-11 3.809e-09
8 SOMATODENDRITIC COMPARTMENT 47 650 1.154e-10 8.426e-09
9 POSTSYNAPSE 34 378 1.828e-10 1.186e-08
10 EXTRACELLULAR MATRIX 36 426 2.995e-10 1.749e-08
11 PROTEINACEOUS EXTRACELLULAR MATRIX 32 356 6.463e-10 3.431e-08
12 EXCITATORY SYNAPSE 23 197 1.206e-09 5.871e-08
13 CELL PROJECTION PART 56 946 3.311e-09 1.487e-07
14 INTRACELLULAR VESICLE 67 1259 6.457e-09 2.693e-07
15 CYTOPLASMIC VESICLE PART 41 601 1.008e-08 3.925e-07
16 PHOSPHATASE COMPLEX 10 48 2.763e-07 1.009e-05
17 CELL SURFACE 44 757 2.957e-07 1.016e-05
18 ENDOCYTIC VESICLE MEMBRANE 17 152 3.305e-07 1.072e-05
19 EXTRACELLULAR SPACE 66 1376 4.125e-07 1.268e-05
20 CELL JUNCTION 58 1151 4.633e-07 1.353e-05
21 VESICLE MEMBRANE 33 512 1.034e-06 2.876e-05
22 CELL BODY 32 494 1.357e-06 3.601e-05
23 DENDRITE 30 451 1.7e-06 4.317e-05
24 TRANSCRIPTION FACTOR COMPLEX 23 298 2.445e-06 5.949e-05
25 ENDOCYTIC VESICLE 21 256 2.568e-06 5.999e-05
26 MEMBRANE REGION 55 1134 3.004e-06 6.748e-05
27 AXON 28 418 3.302e-06 7.143e-05
28 CYTOSKELETON 82 1967 4.329e-06 9.03e-05
29 SITE OF POLARIZED GROWTH 15 149 6.058e-06 0.000122
30 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 6 20 7.38e-06 0.0001437
31 VOLTAGE GATED SODIUM CHANNEL COMPLEX 5 14 1.7e-05 0.0003128
32 CELL CELL JUNCTION 25 383 1.715e-05 0.0003128
33 SARCOLEMMA 13 125 1.767e-05 0.0003128
34 APICAL JUNCTION COMPLEX 13 128 2.281e-05 0.0003918
35 PLASMA MEMBRANE REGION 45 929 2.583e-05 0.000431
36 PRESYNAPSE 20 283 3.925e-05 0.0006367
37 SODIUM CHANNEL COMPLEX 5 17 4.934e-05 0.0007516
38 MEMBRANE MICRODOMAIN 20 288 5.019e-05 0.0007516
39 PLASMA MEMBRANE PROTEIN COMPLEX 29 510 4.839e-05 0.0007516
40 NEURONAL POSTSYNAPTIC DENSITY 8 53 5.247e-05 0.0007661
41 ACTIN BASED CELL PROJECTION 15 181 6.111e-05 0.0008704
42 PLASMA MEMBRANE RAFT 10 86 6.327e-05 0.0008798
43 MICROTUBULE CYTOSKELETON 48 1068 8.907e-05 0.00121
44 RECEPTOR COMPLEX 21 327 0.0001006 0.001336
45 LAMELLIPODIUM 14 172 0.0001292 0.001641
46 T TUBULE 7 45 0.0001271 0.001641
47 FILOPODIUM 10 94 0.0001349 0.001676
48 ENDOPLASMIC RETICULUM LUMEN 15 201 0.0001973 0.0024
49 EXTRACELLULAR MATRIX COMPONENT 11 125 0.0003432 0.004091
50 NEUROMUSCULAR JUNCTION 7 54 0.0004077 0.004762
51 NUCLEAR CHROMATIN 18 291 0.0004849 0.005545
52 AXON PART 15 219 0.0004938 0.005545
53 CYTOSKELETAL PART 57 1436 0.0005065 0.005581
54 MICROVILLUS 8 75 0.0006143 0.006643
55 MICROTUBULE ORGANIZING CENTER 30 623 0.0006385 0.006779
56 CHROMATIN 23 441 0.0009463 0.009868

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Wnt_signaling_pathway_hsa04310 91 146 2.816e-109 1.464e-107
2 Hippo_signaling_pathway_hsa04390 44 154 5.333e-34 1.387e-32
3 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 37 139 1.619e-27 2.807e-26
4 mTOR_signaling_pathway_hsa04150 28 151 1.271e-16 1.652e-15
5 Adherens_junction_hsa04520 18 72 1.621e-13 1.549e-12
6 MAPK_signaling_pathway_hsa04010 34 295 1.787e-13 1.549e-12
7 Focal_adhesion_hsa04510 26 199 7.683e-12 5.707e-11
8 TGF_beta_signaling_pathway_hsa04350 17 84 3.013e-11 1.959e-10
9 Sphingolipid_signaling_pathway_hsa04071 18 118 1.045e-09 5.453e-09
10 cGMP_PKG_signaling_pathway_hsa04022 21 163 1.049e-09 5.453e-09
11 cAMP_signaling_pathway_hsa04024 23 198 1.333e-09 6.302e-09
12 Hedgehog_signaling_pathway_hsa04340 11 47 1.903e-08 8.248e-08
13 Calcium_signaling_pathway_hsa04020 20 182 4.101e-08 1.641e-07
14 Oocyte_meiosis_hsa04114 16 124 1.006e-07 3.738e-07
15 ErbB_signaling_pathway_hsa04012 13 85 2.141e-07 7.424e-07
16 FoxO_signaling_pathway_hsa04068 16 132 2.421e-07 7.87e-07
17 Rap1_signaling_pathway_hsa04015 20 206 3.173e-07 9.706e-07
18 Ras_signaling_pathway_hsa04014 21 232 5.209e-07 1.505e-06
19 PI3K_Akt_signaling_pathway_hsa04151 26 352 1.243e-06 3.402e-06
20 Cellular_senescence_hsa04218 16 160 3.256e-06 8.465e-06
21 Tight_junction_hsa04530 16 170 7.138e-06 1.768e-05
22 VEGF_signaling_pathway_hsa04370 9 59 1.64e-05 3.876e-05
23 Apelin_signaling_pathway_hsa04371 13 137 4.684e-05 0.0001059
24 Cell_cycle_hsa04110 12 124 7.523e-05 0.000163
25 HIF_1_signaling_pathway_hsa04066 10 100 0.0002257 0.0004694
26 Regulation_of_actin_cytoskeleton_hsa04810 15 208 0.0002858 0.0005717
27 Gap_junction_hsa04540 9 88 0.0003899 0.0007509
28 Phosphatidylinositol_signaling_system_hsa04070 9 99 0.0009249 0.001718
29 Cell_adhesion_molecules_.CAMs._hsa04514 11 145 0.001192 0.002138
30 Mitophagy_animal_hsa04137 7 65 0.001262 0.00215
31 Notch_signaling_pathway_hsa04330 6 48 0.001282 0.00215
32 p53_signaling_pathway_hsa04115 7 68 0.001647 0.002676
33 TNF_signaling_pathway_hsa04668 9 108 0.001712 0.002697
34 AMPK_signaling_pathway_hsa04152 9 121 0.003709 0.005673
35 Cytokine_cytokine_receptor_interaction_hsa04060 15 270 0.0039 0.005794
36 Jak_STAT_signaling_pathway_hsa04630 10 162 0.008443 0.0122
37 Phospholipase_D_signaling_pathway_hsa04072 9 146 0.01224 0.01721
38 Autophagy_animal_hsa04140 8 128 0.01639 0.02242
39 ECM_receptor_interaction_hsa04512 6 82 0.01785 0.0238
40 Hippo_signaling_pathway_multiple_species_hsa04392 3 29 0.03633 0.04722
41 Endocytosis_hsa04144 11 244 0.04743 0.06015
42 Apoptosis_multiple_species_hsa04215 3 33 0.05039 0.06239
43 NF_kappa_B_signaling_pathway_hsa04064 5 95 0.09383 0.1135
44 ABC_transporters_hsa02010 3 45 0.1054 0.1246
45 Autophagy_other_hsa04136 2 32 0.1943 0.2245
46 Lysosome_hsa04142 5 123 0.2025 0.2289
47 Necroptosis_hsa04217 6 164 0.2376 0.2628
48 Apoptosis_hsa04210 5 138 0.2726 0.2954
49 Phagosome_hsa04145 5 152 0.342 0.3629
50 Neuroactive_ligand_receptor_interaction_hsa04080 8 278 0.4084 0.4248

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

EMX2OS

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7f-2-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-5p;hsa-miR-224-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-484;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-624-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 40 PRICKLE2 Sponge network -1.057 0.31716 -0.551 0.42536 0.586
2

CECR7

hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-491-5p;hsa-miR-502-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-7-5p 27 PRKCB Sponge network -0.551 0.56177 0.289 0.6299 0.583
3

EMX2OS

hsa-miR-1275;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-192-3p;hsa-miR-19b-1-5p;hsa-miR-26b-3p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-940 18 SFRP1 Sponge network -1.057 0.31716 -0.459 0.49771 0.573
4

CECR7

hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-192-5p;hsa-miR-215-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-361-5p;hsa-miR-532-5p;hsa-miR-582-5p 10 PRICKLE1 Sponge network -0.551 0.56177 -0.398 0.44256 0.538
5

CECR7

hsa-miR-141-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-19b-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-592 10 DAAM2 Sponge network -0.551 0.56177 -0.123 0.86624 0.52
6

EMX2OS

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-185-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-30b-3p;hsa-miR-30d-3p;hsa-miR-362-3p;hsa-miR-505-5p;hsa-miR-590-3p;hsa-miR-93-5p 17 TCF7L1 Sponge network -1.057 0.31716 -0.403 0.47966 0.509
7

CECR7

hsa-miR-130b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-940 14 MAPK10 Sponge network -0.551 0.56177 -0.278 0.49976 0.504
8

EMX2OS

hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-375;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-484;hsa-miR-505-5p;hsa-miR-548o-3p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-940 44 FZD4 Sponge network -1.057 0.31716 -0.088 0.9264 0.501
9

CECR7

hsa-miR-1275;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-192-3p;hsa-miR-19b-1-5p;hsa-miR-26b-3p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-940 14 SFRP1 Sponge network -0.551 0.56177 -0.459 0.49771 0.494
10

CECR7

hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-375;hsa-miR-429;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-505-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-940 40 FZD4 Sponge network -0.551 0.56177 -0.088 0.9264 0.486
11

EMX2OS

hsa-miR-1275;hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-93-3p 13 FZD1 Sponge network -1.057 0.31716 0.051 0.95908 0.447
12

EMX2OS

hsa-miR-141-5p;hsa-miR-144-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-1976;hsa-miR-19b-3p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-421;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-592 13 DAAM2 Sponge network -1.057 0.31716 -0.123 0.86624 0.445
13

CECR7

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-590-3p;hsa-miR-93-5p 15 TCF7L1 Sponge network -0.551 0.56177 -0.403 0.47966 0.437
14

CECR7

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7f-2-3p;hsa-miR-130b-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-361-5p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 38 PRICKLE2 Sponge network -0.551 0.56177 -0.551 0.42536 0.432
15

MEG3

hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-98-5p 25 FZD4 Sponge network -0.433 0.33816 -0.088 0.9264 0.417
16

EMX2OS

hsa-miR-130b-3p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-454-3p;hsa-miR-548o-3p;hsa-miR-590-3p;hsa-miR-940 15 MAPK10 Sponge network -1.057 0.31716 -0.278 0.49976 0.408
17

EMX2OS

hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-452-3p;hsa-miR-484;hsa-miR-502-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p 22 PRKCB Sponge network -1.057 0.31716 0.289 0.6299 0.407
18

MEG3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-30b-3p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-93-5p 15 TCF7L1 Sponge network -0.433 0.33816 -0.403 0.47966 0.398
19

MIAT

hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-301a-3p;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-505-5p;hsa-miR-92a-3p;hsa-miR-98-5p 18 FZD4 Sponge network 0.118 0.86338 -0.088 0.9264 0.397
20

MEG3

hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-19b-3p;hsa-miR-221-5p;hsa-miR-26a-2-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-491-3p;hsa-miR-576-5p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 26 PRICKLE2 Sponge network -0.433 0.33816 -0.551 0.42536 0.389
21

CECR7

hsa-miR-1275;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-590-3p 10 FZD1 Sponge network -0.551 0.56177 0.051 0.95908 0.388
22

HCG11

hsa-let-7g-3p;hsa-miR-107;hsa-miR-128-3p;hsa-miR-15b-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-33a-3p;hsa-miR-378a-5p;hsa-miR-511-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 11 VANGL2 Sponge network -0.419 0.63279 -0.77 0.42866 0.385
23

CECR7

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1226-3p;hsa-miR-1227-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-331-3p;hsa-miR-335-5p;hsa-miR-532-3p;hsa-miR-589-3p 13 WNT9A Sponge network -0.551 0.56177 0.153 0.81191 0.363
24

EMX2OS

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1227-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-185-3p;hsa-miR-193a-3p;hsa-miR-32-5p;hsa-miR-331-3p;hsa-miR-335-5p;hsa-miR-424-5p;hsa-miR-532-3p;hsa-miR-589-3p 16 WNT9A Sponge network -1.057 0.31716 0.153 0.81191 0.357
25

MEG3

hsa-miR-146a-5p;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-192-3p;hsa-miR-19b-1-5p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-96-5p 13 SFRP1 Sponge network -0.433 0.33816 -0.459 0.49771 0.357
26

EMX2OS

hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-335-5p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-940 12 CAMK2B Sponge network -1.057 0.31716 -2.17 0.00982 0.338
27

MEG3

hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-577;hsa-miR-93-3p 11 FZD1 Sponge network -0.433 0.33816 0.051 0.95908 0.335
28

HCG11

hsa-let-7a-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-197-3p;hsa-miR-212-3p;hsa-miR-26a-1-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 16 PRICKLE2 Sponge network -0.419 0.63279 -0.551 0.42536 0.335
29

ZNF883

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7f-2-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-320c;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-5p 30 PRICKLE2 Sponge network -0.913 0.16772 -0.551 0.42536 0.315
30

CECR7

hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-200b-5p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-30c-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p 12 NFATC2 Sponge network -0.551 0.56177 -0.208 0.70733 0.302
31

CECR7

hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-491-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-940 12 CAMK2B Sponge network -0.551 0.56177 -2.17 0.00982 0.298
32

MEG3

hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-577;hsa-miR-7-1-3p 13 WNT5A Sponge network -0.433 0.33816 -0.11 0.91453 0.296
33

EMX2OS

hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-20a-5p;hsa-miR-215-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-486-5p;hsa-miR-590-3p 10 FZD7 Sponge network -1.057 0.31716 -0.142 0.88753 0.278
34

EMX2OS

hsa-miR-193a-3p;hsa-miR-221-3p;hsa-miR-27a-3p;hsa-miR-324-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-374b-5p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-590-3p 10 DKK2 Sponge network -1.057 0.31716 -0.674 0.21846 0.268
35

MEG3

hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 17 PRKCB Sponge network -0.433 0.33816 0.289 0.6299 0.266
36

ZNF883

hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-182-5p;hsa-miR-19b-1-5p;hsa-miR-26b-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-576-5p 11 SFRP1 Sponge network -0.913 0.16772 -0.459 0.49771 0.265
37

EMX2OS

hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-200b-5p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p 13 NFATC2 Sponge network -1.057 0.31716 -0.208 0.70733 0.257

Quest ID: b3f0d9b659932b5c7f587ef178b1c4c4